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Abstract
English
In healthy subjects, glucose regulation relies on a complex control sys-
tem that keeps blood glucose level within a narrow range around its basal
value. A common element that offers a net benefit for most individuals with
and without diabetes is regular physical activity, which is known to enhance
insulin sensitivity, improve glycemic control and reduce the risk of cardiovas-
cular mortality.
Nowadays numerous studies have demonstrated increased rate of glucose up-
take (Rd) and rate of endogenous glucose production (EGP) during physical
activity in individuals with and without diabetes in the postabsorptive state,
while very few have examined the effects of exercise in the postprandial state
although many people, with and without diabetes, exercise a few hours after
a meal. A method for the quantification of the effect and effect size of exer-
cise on insulin sensitivity and a physiological model quantitatively describing
the effect of exercise on glucose turnover in the postprandial state have never
been developed. This represents a significant knowledge gap, especially in
type 1 diabetes, because this information could be incorporated into cur-
rently available artificial pancreas control algorithms, thus extending their
applicability to treat people with type 1 diabetes. However, such tools will
need to be developed and tested in healthy subjects before validating in those
with diabetes.
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In this work data of 12 healthy individuals who underwent a triple-tracer
mixed-meal and a moderate-intensity exercise session 2 hours after meal in-
gestion for 75 minutes have been used. The tracer-to-tracee clamp method
was used to accurately estimate postprandial glucose turnover continuously
after the meal, during and after exercise by clamping tracer-to-tracee ratios
in order to minimize non-steady-state errors. Since it is almost impossible
to realize a perfect clamp of the plasma tracer-to-tracee ratio, the use of
models, to compensate the non-steady-state errors, is needed. Use of mod-
els requires the estimation of derivatives both for tracer-to-tracee ratio and
glucose signals and, due to ill-conditioning, this issue is generally solved via
regularized deconvolution. However, an implicit assumption of standard reg-
ularized deconvolution is that, in a Bayesian embedding, expectations on
smoothness of the unknown input can be formalized by describing it a priori
as the multiple integration of a stationary white noise process but, because
of physical activity, signals represented marked nonstationarity. We solved
the problem by resorting to an improved stochastic deconvolution method,
in order to account for nonstationarity introduced by exercise.
Fluxes analysis showed that during exercise session EGP rose, which can be
explained by both falling insulin and rising glucagon concentrations, while
glucose concentrations fell and Rd plateaued, which can be explained by
increasing muscle uptake by both insulin-independent and -dependent mech-
anisms.
In order to quantify the effect and effect size of exercise on net insulin
sensitivity (SI), i.e. the ability of insulin to stimulate glucose disposal and
suppress endogenous glucose production, we developed a method able to cal-
culate net insulin sensitivity and evaluate the relative contribution of liver
and disposal insulin sensitivity based on glucose fluxes data. SI was estim-
ated first using data of first 2 hours after the meal, i.e. in absence of physical
activity, and then using the data of the whole experiment, i.e. in presence
of physical activity. We found that net SI increases by almost 75% during
moderate-intensity exercise and that this increase is associated to insulin-
dependent glucose disposal. Furthermore, we validated these results by cal-
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culating an index of net insulin sensitivity, both in absence and presence
of physical activity, based on an integral formula using glucose and insulin
concentration data. We found a strong correlation between net SI indices
calculated with the two methods.
The results on effect size of physical activity on SI have been incorporated
into the UVA/Padova T1DM simulator in order to suggest the best strategy
that could be adopted during artificial pancreas clinical trials that involves
a session of moderate physical activity. We showed that, in order to prevent
hypoglycemia during and after exercise, any control algorithm would benefit
by knowing in advance of upcoming physical activity and, if patient-specific
basal insulin reduction pattern is not available, an optimal basal reduction
strategy has been proposed.
However, the method for the quantification of the effect size of exercise
on insulin sensitivity was not able to tease out the insulin-independent effect
of exercise on glucose uptake. Therefore, to discriminate the effect of exercise
on insulin-dependent and -independent glucose turnover, the development of
a mathematical model to assess the effect of physical activity on glucose kin-
etics has been approached. A set of models of increasing complexity have
been developed and selection was tackled using standard criteria (e.g. abil-
ity to describe the data, precision of parameter estimates, model parsimony,
residual independence). The models proposed well fitted the data and al-
lowed the estimation of physiologically interpretable parameters quantifying
the effect of physical activity on glucose turnover.
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Italiano
In soggetti sani, il controllo della glicemia si basa su un complesso sis-
tema di regolazione che permette di mantenere il livello di glucosio nel sangue
all'interno di un range ristretto che oscilla attorno al suo valore basale. Ben
noti sono i netti benefici offerti dall'attività fisica per la maggior parte degli
individui, sia sani che diabetici, come, per esempio, l'aumento della sensibilità
insulinica, il miglioramento del controllo glicemico e la riduzione del rischio
di mortalità cardiovascolare. Oggigiorno in molti studi è stato dimostrato
che, sia in soggetti sani che diabetici, durante lo stato post-assorbitivo vi è
un aumento dell'utilizzazione (Rd) e della produzione endogena di glucosio
(EGP), mentre in pochissimi studi sono stati analizzati gli effetti dell'attività
fisica durante lo stato post-prandiale, sebbene moltissime persone, sane e
diabetiche, siano solite praticare attività fisica poche ore dopo un pasto.
Fino ad ora, comunque, non sono ancora stati sviluppati né un metodo
per la quantificazione dell'effetto dell'attività fisica sulla sensibilità insulin-
ica né un modello che descrivi quantitativamente l'effetto dell'attività fisica
sull'utilizzazione del glucosio, soprattutto durante lo stato post-prandiale.
Ciò rappresenta un importante gap dal punto di vista conoscitivo soprat-
tutto per soggetti diabetici di tipo 1 in quanto, l'utilizzazione di questa in-
formazione permetterebbe di estendere i range di applicabilità degli algoritmi
di controllo oggigiorno utilizzati per la realizzazione del pancreas artificiale
anche in queste particolari condizioni sperimentali. Tuttavia, questi metodi
devono ovviamente essere sviluppati e testati in soggetti sani prima di poterli
validare in soggetti affetti da diabete.
In questo lavoro sono stati utilizzati dati provenienti da 12 soggetti sani
sottoposti ad un protocollo di triplo tracciante con pasto misto ed una ses-
sione di esercizio fisico di moderata intensità, 2 ore dopo il pasto, della durata
di 75 minuti. Al fine di stimare accuratamente ed in maniera continua
il turnover post-prandiale del glucosio durante tutto l'esperimento è stata
utilizzata la tenica del clamp del rapporto tracciante-tracciato il cui obiettivo
consiste nel minimizzare gli errori di stato non stazionario clampando i rap-
ix
porti tracciante-tracciato ottenuti. Tuttavia, siccome a livello pratico è quasi
impossibile realizzare il clamp perfetto del rapporto tracciante-tracciato
nel plasma, si rende necessario l'impiego di modelli al fine di compensare gli
errori di stato non stazionario. A sua volta, l'utilizzo di modelli necessita
della stima delle derivate sia dei rapporti tracciante-tracciato che del segnale
glicemico e, generalmente, questo problema viene approcciato mediante la
tecnica di deconvoluzione regolarizzata. Tuttavia, in un contesto bayesiano,
la tecnica di deconvoluzione regolarizzata standard assume implicitamente
che l'informazione sulla regolarità del segnale incognito in ingresso possa es-
sere descritta a priori mediante un processo di rumore bianco stazionario
plurintegrato ma tuttavia, a causa dell'esercizio fisico, i segnali utilizzati
presentano forti non stazionarietà. Al fine di tener conto dell'effetto di non
stazionarietà introdotto dall'esercizio fisico, questo problema è stato approc-
ciato utilizzando un metodo di deconvoluzione stocastica migliorata.
Infine, nei risultati così ottenuti, è stato possibile osservare, durante l'attività
fisica, un forte aumento dell'EGP, probabilmente dovuto ad una contempora-
nea riduzione dell'insulina ed un aumento della concentrazione di glucagone
nel plasma, mentre vi è una riduzione della concentrazione di glucosio con il
raggiungimento di un plateau da parte di Rd, che potrebbe essere associato
ad un aumento dell'utilizzazione del glucosio mediante meccanismi insulino-
dipendenti ed -indipendenti.
Al fine di poter quantificare l'effetto dell'esercizio fisico sulla sensibil-
ità insulinica (SI), ossia la capacità dell'insulina di stimolare l'utilizzazione
del glucosio ed inibirne la produzione endogena, è stato sviluppato un met-
odo, basato sui flussi post-prandiali di glucosio, per stimare tale effetto sulla
sensibilità insulinica totale e valutarne il relativo contributo esercitato sulla
sensibilità insulinica epatica e tessutale. Tale metodo prevede di stimare due
valori di SI: uno sfruttando solo i dati delle prime 2 ore dopo il pasto, ossia
in assenza di attività fisica, e l'altro sfruttando i dati dell'intero esperimento,
ossia in presenza di attività fisica. I risultati ottenuti hanno dimostrato un
aumento di circa il 75% della sensibilità insulinica totale dovuto all'effetto
esercitato dall'attività fisica e che questo effetto era principalmente associ-
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ato ad un aumento della sensibilità insulinica tessutale. Questi risultati,
inoltre, sono stati validati calcolando un indice di sensibilità insulinica appli-
cando sempre lo stesso razionale, ossia in assenza e presenza di attività fisica,
basato su una formula integrale precedentemente pubblicata che utilizza dati
di glucosio ed insulina plasmatica. Gli indici di sensibilità insulinica ottenuti
con i due metodi si sono dimostrati fortemente correlati tra loro, validando
così il nuovo indice proposto di sensibilità insulinica basato sui flussi post-
prandiali di glucosio.
Questi risultati sono stati inoltre implementati nel simulatore UVA/Padova
del diabete di tipo 1 (T1DM) al fine di poter individuare una strategia di ot-
timizzazione della terapia insulinica durante i trials clinici per la realizzazione
del pancreas artificiale in cui fosse prevista una sessione di esercizio fisico.
Con questo studio di simulazione è stato possibile dimostrare che, al fine di
prevenire fenomeni di ipoglicemia, un qualsiasi algoritmo di controllo trar-
rebbe beneficio dal conoscere in anticipo eventuali sessioni di attività fisica
futura e, in caso di una mancanza di informazioni a priori sulla terapia stand-
ard paziente-specifica, è stata proposta una strategia ottima di riduzione di
infusione di insulina basale durante l'attività fisica che si è rivelata essere
sicura ed efficace durante gli studi di simulazione.
Il metodo proposto per la quantificazione dell'effetto dell'esercizio fis-
ico sulla sensibilità insulinica, tuttavia, non permette di discriminare il con-
tributo dell'esercizio fisico sull'utilizzazione insulino-indipendente del gluc-
osio. Per questo motivo, al fine di caratterizzare l'effetto dell'esercizio fisico
sull'utilizzazione del glucosio insulino-dipendente ed -indipendente, è stato
sviluppato un modello matematico per quantificare l'effetto dell'esercizio fis-
ico sulla cinetica del glucosio. Sono stati sviluppati ed implementati una
serie di modelli di diversa complessità e la selezione del modello ottimo è
stata affrontata confrontando le prestazioni dei modelli sulla base di cri-
teri standard (capacità di descrivere i dati, precisione della stima dei para-
metri, parsimonia, casualità dei residui). Infine i modelli proposti hanno
dimostrato di descrivere correttamente i dati sperimentali e di permettere
un'interpretazione fisiologica dei parametri stimati caratterizzanti la quanti-
xi
ficazione dell'effetto dell'esercizio fisico sulla cinetica del glucosio.
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Glossary
T1DM Type 1 Diabetes Mellitus
T2DM Type 2 Diabetes Mellitus
CLC Closed-Loop Control
CRU Clinical Research Unit
Ra Rate of total glucose appearance
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EGP Endogenous glucose production
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SA Specific activity
TTR Tracer-to-tracee ratio
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SI Insulin Sensitivity
GE Glucose Effectiveness
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1
Introduction
1.1 Background
In healthy subjects, glucose regulation relies on a complex control sys-
tem that keeps blood glucose level within a narrow range around its basal
value. The target blood glucose range is usually considered between 70 and
180 mg/dL. Hypoglycemia is identified when plasma glucose concentration
falls below 70 mg/dL, while hyperglycemia when glucose concentration raises
over 180 mg/dL [132] and both conditions are dangerous in the short and
long term, respectively. It is crucial that plasma glucose level does not de-
crease under 70 mg/dL since this can cause complications, and in particular
of the brain, given that glucose is the predominant metabolic fuel. Hypogly-
cemia can also alter cardiac conduction abnormalities leading to cardiac
arrhythmias. Thus, the prevention of hypoglycemia is critical to survival.
On the other hand, the chronic hyperglycemia leads to micro-vascular and
macro-vascular complications which include limb loss, blindness, ischemic
heart disease, and end-stage renal disease [132134].
Comprehension of the mechanisms that regulate plasma glucose have greatly
evolved since the discovery in the 1920s of the peptide hormone insulin, which
was considered the principal actor of glucose homeostasis. Insulin is secreted
by β-cells in response to high levels of plasma glucose, promoting glucose
utilization by tissues and inhibiting endogenous glucose production by the
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liver and kidney. In the 1950s, pancreatic α-cells hormone glucagon was dis-
covered. It is secreted in response to a fall in plasma glucose concentration
below the hypoglycemic threshold, and acts by stimulating hepatic glycogen-
olysis and ultimately gluconeogenesis, thus raising EGP and consequently
increasing plasma glucose concentration. All these elements lead to a bi-
hormonal view of glucose regulation, where insulin was the key regulatory
hormone of glucose disappearance and glucagon the major regulator of gluc-
ose appearance.
Impairment of the glucose regulatory system is the cause of several meta-
bolic disorders, such as diabetes. Diabetes is a chronic disease, character-
ized by the inability of the body to control the concentration of glucose
(glycaemia) in blood. In particular, deficiency in the secretion and action
of insulin represents the main cause of impaired glucose control, although
such impairments can have very different genesis. Two major pathologies are
usually considered: type 1 and type 2 diabetes (T1DM and T2DM, respect-
ively).
Type 1 diabetes is the result of immune-mediated destruction of the pan-
creatic β-cells in the islets of Langerhans, i.e. the site of insulin production
and secretion. In general, the disease occurs in childhood and adolescence
(although it can occur at all ages) and is characterized by absolute insulin
deficiency. Consequently, affected individuals require exogenous insulin in-
jections to compensate the lack of secretion from the pancreas and sustain
life. As a rule, obesity does not play a part in the pathogenesis of T1DM,
although obesity in T1DM is associated with the development of cardiovas-
cular complications.
Type 2 diabetes occurs because insulin secretion is inadequate and cannot
overcome the prevailing defects in insulin action, resulting in hyperglycemia.
Excess caloric intake, inactivity and obesity all play parts in the pathogen-
esis of T2DM. In general, it is a disease that occurs with increasing fre-
quency with increasing age and is uncommon before age 40 (although there
are important exceptions). In addition, people with T2DM are more likely
to have associated adverse cardiovascular risk factors such as dyslipidemia
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and hypertension and are major components of health care spending [113].
Conventional therapy for T2DM consists of a combination of diet, regular
physical activity and drugs such as oral hypoglycemic agents, sulfonylureas
and insulin.
The prevalence of diabetes mellitus is increasing dramatically all over the
world and its global incidence has been increasing steadily in the past sev-
eral years. Ninety percent of the world population with diabetes is type 2,
with type 1 diabetes comprising between 5%-10%. Over time, uncontrolled
diabetes leads to complications, in particular: diabetic retinopathy, which
leads to blindness; diabetic neuropathy, which increases the risk of foot ul-
ceration and limb loss; and diabetic nephropathy leading to kidney failure.
In addition, there is an increased risk of heart disease and stroke, with 50% of
people with diabetes dying for them. Finally, the overall risk of dying among
people with diabetes is at least double the risk of their peers without diabetes.
A common element that offers a net benefit for most individuals with and
without diabetes is regular physical activity, which can include structured ex-
ercise in a variety of forms. Regular physical activity is known to enhance
insulin sensitivity, increase cardiorespiratory fitness, improve glycemic con-
trol, reduce the risk of cardiovascular mortality, decrease fatty mass, arterial
pressure and incidence of the T2DM [72, 106, 126]. It is well established that
exercise increases rates of glucose uptake (Rd) and that rates of endogenous
glucose production (EGP) must increases to meet the increased metabolic
demands of the exercising muscle to prevent hypoglycemia [28, 43, 121, 125].
These changes in glucose fluxes are facilitated by falling insulin and rising glu-
cagon and catecholamine levels during exercise in healthy individuals [131].
Numerous factors determine the rate of glucose uptake during and after exer-
cise. During exercise, one of the most important regulatory responses is an in-
crease in blood flow to the contracting skeletal muscles [2, 92]. The increase in
blood flow provides ample substrate to the working muscles, and thus, glucose
availability is usually not the rate-limiting factor for glucose utilization when
exercise is performed under normal physiological conditions. The principal
mechanisms by which exercise increases glucose uptake in skeletal muscle is
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through the translocation of a glucose transporter protein, i.e. GLUT-4 iso-
form, from an intracellular compartment to the surface cell [48, 49, 114, 128]
and increasing its transcription [39, 95], and that this is independent of in-
sulin [88, 91, 97, 123]. In addition to the acute effects of exercise to increase
muscle glucose uptake, the postexercise period is characterized by muscle
being more sensitive to the action of insulin [51, 52], even if the mechanisms
are still under investigation.
The therapeutic effects of exercise in the treatment of diabetes have been
clearly recognized, including decreased insulin requirements, improved car-
diovascular fitness and blood lipid profiles. However, in some cases, the
increase in glucose uptake due to exercise can lead to hypoglycemic episodes
in insulin-treated diabetic people and may exacerbate hyperglycemia and
promote ketosis in poorly metabolic-controlled patients [5]. In some studies
on T1DM subjects it was showed that exercise training improve insulin sens-
itivity but not glucose control [122, 127]. However, the lack of improvement
in glucose control is mainly due to to the fear of hypoglycemia leading to
overcompensation with additional carbohydrate intake or excessive insulin
infusion reduction and/or counterregulatory hormones response.
Although numerous studies have demonstrated increased Rd and EGP
during physical activity in individuals with and without diabetes [46, 64]
in the postabsorptive state, very few have examined the effects of exercise
in the postprandial state in individuals with and without type 2 diabetes
[17, 18, 58, 65, 74, 75] and none in individuals with type 1 diabetes. Further-
more, very few studies [27] have used methods that minimize fluctuations
in tracer-to-tracee specific activity to enable accurate continuous (every 10
min) measurement of glucose turnover and during the transition from rest to
exercise in nondiabetic subjects.
Models of insulin action and secretion in response to physiological perturba-
tions (e.g., oral glucose or mixed-meal challenges) have been developed and
validated in humans with and without type 2 diabetes. However, none of
these methods have been tested or validated when these perturbations are
further challenged by exercise. This is an important practical issue related
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to the model that needs to be tested since many people, with and without
diabetes, exercise a few hours after a meal. Furthermore, lack of development
and validation of such physiological models of whole-body insulin sensitivity
during exercise, especially in the postprandial state, precludes quantification
of the effect size of exercise on insulin sensitivity. This represents a significant
knowledge gap that would be important to supply, because accurate quanti-
fication of exercise effect on insulin sensitivity, especially in people with type
1 diabetes, could perhaps be incorporated into currently available artificial
pancreas control algorithms, thus extending their applicability and wider use
to treat people with type 1 diabetes. However, such models will first need to
be developed and tested in healthy subjects before validating in those with
diabetes.
1.2 Aim
The general aim of this thesis is to develop a methodology to accurately
quantifying the effect of moderate-intensity physical activity on postprandial
glucose turnover in healthy subjects. The aim of this work can be divided
into the following tasks:
• To establish a novel method for the estimation of postprandial glucose
turnover during physical activity with the state-of-the-art techniques.
• To propose a method for the quantification of the effect size of exercise
on insulin sensitivity when exercise is part of the postprandial period.
• To propose a whole-body mathematical model describing the effect of
physical activity on glucose-insulin system.
1.3 Outline of the thesis
The thesis is articulated as follows:
Chapter 2 presents a brief overview on some aspects of exercise physiology
6 Introduction
useful for the comprehension of the results throughout the work.
Chapter 3 describes the experimental protocol used for the estimation of
postprandial glucose fluxes, quantification of insulin sensitivity and model-
ing glucose kinetics during physical activity in healthy subjects.
Chapter 4 describes the triple-tracer technique and presents the methods
used for an accurate estimation of postprandial glucose fluxes during phys-
ical activity.
Chapter 5 presents a method for the quantification of the effect size of phys-
ical activity on insulin sensitivity based on postprandial glucose fluxes and
which is also validated with a well-established method based on glucose and
insulin data. Moreover, the obtained results are used in a simulation study
for the optimization of insulin therapy in T1DM patients during exercise.
Chapter 6 presents a whole-body mathematical model to assess the effect of
physical activity on glucose kinetics.
The results obtained in this work as well as emerged open questions and
future direction of research are discussed in Conclusions.
2
Exercise Physiology
2.1 Introduction
In this Chapter a brief overview on some aspects of exercise physiology
that are useful for the comprehension of the results throughout the work is
presented. The main mechanisms of the complex glucose regulation system
during exercise are first described, then particular attention is focused on de-
scribing the effect of exercise in increasing muscle glucose uptake and insulin
sensitivity. In the end, a brief introduction on the role of physical activity in
diabetes is presented.
2.2 Glucose regulation during exercise
Exercise is known to increase muscle glucose uptake from blood. The
maintenance of nearly normal-resting blood glucose level is always of primary
importance, in particular for the brain given that glucose is the predominant
metabolic fuel, at variance with the muscle which can recur to alternative
substrates. The coordinated physiological response to maintain blood gluc-
ose homeostasis during exercise is governed by chemical mediators released
by both the autonomic nervous and hormonal systems to help in maintaining
an adequate blood glucose level. When blood glucose falls during exercise,
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powerful conterregulatory controls come into play to increase glucose pro-
duction and maintain circulating glucose concentration in two ways. The
first one is via the increased release into the blood of glucose from the liver,
kidneys and gut. The second approach is to raise the circulating levels of al-
ternative substances to glucose and deliver these to active tissues in order to
slow glucose and glycogen utilization, thereby delaying fatigue during exer-
cise. However, at the start of exercise and during moderate to hard intensity
exercise, feed-forward mechanisms operate to maintain or raise blood gluc-
ose concentration. Conversely, if blood glucose concentration falls during
prolonged submaximal exercise, powerful feedback responses are elicited to
maintain blood glucose level [12].
All these mechanisms are governed by a complex system of redundant con-
 
Figure 2.1: Substrates and signals implicated in control of glucose fluxes to work-
ing muscle during euglycemic exercise. This scheme illustrates the complex meta-
bolic, neural and endocrine responses that normally prevent hypoglycemia, despite
the increase in glucose associated with exercise. Broken lines represent controlling
signals, and solid lines represents substrates fluxes. Certain aspects of the scheme,
such as Sensors, still remain speculative. The scheme is largely based on studies of
the dog engaged in moderate-intensity treadmill exercise. Adapted from [14].
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trols (Figure 2.1), mainly regulated by chemical mediators secreted by the
hormonal (feedback control), such as insulin and its antagonist glucagon,
and autonomic nervous system (feed-forward control), such as catecholam-
ines. Among the glucoregulatory hormones in resting people, insulin is the
most important since it stimulates glucose uptake and inhibit glucose pro-
duction, thus its action during exercise is fundamental to avoid hypoglycemic
episodes. Whereas insulin is secreted when blood glucose levels are high,
e.g. after a meal, glucagon is secreted when blood glucose levels are low,
enhancing glycogenolysis and increasing gluconeogenesis. In terms of the
antagonistic effects of insulin and glucagon, possibly the best way to con-
ceive of differing effects is to focus on their ratio (I/G): during prolonged
exercise, the ratio I/G is lower due to an increase in blood glucagon and a
decrease in insulin levels thus stimulating glucose production. At exercise on-
set, feed-foward regulation involves catecholamines, e.g. norepinephrine and
epinephrine, stimulating muscle and liver glycogenolysis, lipolysis in adipose
tissue and suppressing insulin secretion, causing a fall in insulin concentra-
tion even if glucose rises. Furthermore, other important hormones exert their
actions on maintaining blood glucose level such as cortisol, helping the gluca-
gon in the gluconeogenic function by stimulating proteolysis in muscle, and
growth hormone, stimulating the release of fatty acids from adipose tissue as
alternative fuels and postponing the time when glucose and glycogen stores
become critical.
2.3 Exercise effect on glucose transport and in-
sulin sensitivity
In the exercising muscle, the increased need for metabolic fuel is met
partially through an increase in the utilization and uptake of glucose. To
meet this increased need, there is a significant elevation in the rate of glyco-
genolysis and an insulin-like effect to increase the uptake of glucose from
circulation in the contracting muscles. In addition to the acute effects of
exercise, the period after exercise is characterized by the muscle being more
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sensitive to the action of insulin, an effect that facilitates the resynthesis of
muscle glycogen stores [50, 57, 60, 99, 101]. Initially it was thought that the
increase in glucose transport process in skeletal muscle induced by exercise
requires the presence of insulin [96]. In earlier study in perfused rat hind-
limb [45], it was found that the enhancement of glucose uptake after exercise
occurs in two phases: the first is independent of added insulin, and, as this
increase in glucose transport reverses, it is replaced by an increase in insulin
sensitivity [45, 60]. Subsequent studies have established that contractions
stimulate glucose transport in the complete absence of insulin [91, 123], and
that maximal effects of contractions and insulin are additive [59, 124] stim-
ulating glucose transport by separate pathways [80].
When exercise is performed under normal physiological conditions, one of
the most important regulatory responses is an increase in blood flow [2, 92],
which provides ample substrate to the working muscles, while glucose trans-
port is considered to be the rate-limiting factor in glucose utilization. Glucose
transport in skeletal muscle occurs primarily by facilitated diffusion, utilizing
carrier proteins for transport of the substrate across the membrane. GLUT-4
is the major isoform present in both human and rat skeletal muscle, whereas
the GLUT-1 and GLUT-5 isoforms are expressed at a much lower abundance
[67]. Exercise and insulin are the major mediators of glucose transport activ-
ity in muscle: it follows a saturation kinetics and most reports have shown
that exercise and insulin increase glucose transport through an increase in
the maximal velocity (Vmax) without an appreciable change in the substrate
concentration at which glucose transport is half maximal (Km) [8].
There is substantial evidence that exercise increases glucose uptake in skeletal
muscle through the translocation of GLUT-4 isoform from an intracellular
compartment to the surface of the cell [48, 49, 114, 128] and increasing its
transcription [39, 95], while a single bout of exercise does not alter the abund-
ance of the other plasma membrane proteins [48, 49, 71]. Similar to the effect
of exercise, insulin is known to cause GLUT-4 translocation in skeletal muscle
[47, 49]. However, even if blood flow is increased during exercise and thus
this could lead to an increased delivery of insulin to the working muscle, the
exercise-induced recruitment of GLUT-4 to the plasma membrane has been
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demonstrated to be independent of insulin [47, 88, 91, 123]. Thus, contraction
in the absence of insulin, as well as insulin alone, can independently result in
the movement of glucose transporters to the plasma membrane (Figure 2.2).
The increase in muscle glucose transport with the combination of a maximalGLUT-4 translocation in skeletal muscle.  
Hayashi T et al. Am J Physiol Endocrinol Metab 
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Figure 2.2: GLUT-4 translocation in skeletal muscle. Muscle contractions and in-
sulin cause translocation of GLUT-4 glucose transporter proteins to plasma mem-
brane and transverse tubules (T-tubules). GLUT-1 and GLUT-5 are present in
plasma membrane. The subcellular origin of GLUT-4-containing vesicles is not
clear, but exercise and insulin appear to recruit distinct GLUT-4-containing ves-
icles and/or mobilize different pools of GLUT-4 proteins. Adapted from [50, 57].
contraction stimulus and a maximal insulin stimulus is greater than the ef-
fect of either contraction or insulin alone [45, 124]. Thus the combination of
contraction and insulin can have additive or partially additive effect on gluc-
ose transport, which may be associated with an additive effect on GLUT-4
recruitment on plasma membrane, and these findings support the hypothesis
that the two stimuli can act independently with different mechanisms. In
fact, there is evidence that there are two distinct intracellular locations or
pools of glucose transporters in skeletal muscle, one that responds to exercise
and one to insulin [40]. However, as recently reviewed [111], studies of adipose
cells suggest that there is a low rate of continuous recycling of GLUT-4 in
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the basal state, and that insulin acts primarily through increasing trans-
porter exocytosis. In skeletal muscle, it is not known if the exercise-induced
recruitment of GLUT-4 occurs through the regulation of vesicular exocytosis
or other mechanisms.
Increased insulin sensitivity in skeletal muscle glucose uptake is usually
observed after a single bout of exercise [96] and this effect can persist for sev-
eral hours following the cessation of exercise [45, 60]. However, one-legged
exercise models in humans have demonstrated that the exercise-induced in-
crease in insulin sensitivity for glucose uptake is a local phenomenon restric-
ted to the exercised muscle [98].
The molecular basis for this phenomenon has not been completely elucidated
but appears to be dependent on multiple factors. The rate that glucose is
stored or metabolized in the postexercise period may be involved in the re-
versal of the increased insulin sensitivity of muscle glucose uptake and may
partially explain the different durations of this effect [86, 96]. While insulin
clearance rates and insulin binding to its receptor seem to not change after
exercise [98, 118], another possible mechanism which can contribute to this
effect comes from studies in which the postexercise period is not characterized
by increased insulin sensitivity, i.e. when intact muscles are isolated, washed
and then contracted in vitro [16]. This work and the subsequent report [44]
have suggested that a serum factor is required for the effects of contraction
to enhance insulin sensitivity. However, the effect of exercise on increasing
sensitivity is not only limited to insulin, in fact the effect of hypoxia on gluc-
ose transport is also markedly amplified after exercise [16]. Thus, there may
be multiple factors that regulate the enhanced muscle insulin sensitivity for
glucose uptake in the postexercise period, in fact this phenomenon may be
regulated by a combination of humoral factors, autocrine/paracrine mechan-
isms and muscle glycogen concentrations.
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2.4 Role of exercise in diabetes
Regular physical activity is known to have several potential benefits that
apply to both diabetic and nondiabetic individuals. In addition to lowering
blood glucose due to exercise-induced glucose uptake and increasing insulin
sensitivity, regular exercise improves several risk factors for cardiovascular
disease. Psychological benefits of exercise, such as an increased sense of
well-being, improved self-esteem and enhanced quality of life may also be
important for those with either type 1 and type 2 diabetes [61].
Although persons with diabetes may derive many benefits from regular phys-
ical activity, there are also a number of hazards that make exercise difficult
to manage if not properly addressed. In T1DM individuals, risks of hy-
poglycemia during or after exercise, in case of hyperinsulinemic state, or
of worsening metabolic control, in case of insulin-deficient state, have been
recognized. In T2DM individuals, treated by diet alone, exercise usually res-
ults in a decrease in glucose concentration toward normal levels and it can
be used safely as an adjunct to diet to achieve weight loss and improved
insulin sensitivity, while, in individuals treated with sulfonylureas or insulin,
an increased risk of developing hypoglycemia during or following exercise has
been recognized.
Exercise in type 1 diabetes
Shortly after the introduction of insulin, exercise has been demonstrated
to strengthen the hypoglycemic effect of injected insulin [76] thus leading
to decreased insulin requirements to overcome the increased risk of hypogly-
cemic reactions in T1DM patients.
One major problem for the T1DM patient is that plasma insulin concentra-
tions do not decrease during exercise as in normal subjects and may even
increase when insulin injection is administered in a short time interval from
the onset of exercise, particularly if the injection site is in an exercising part
of the body [68]. The major effect of sustained insulin levels is related to
the inhibition of both glycogenolysis and gluconeogenesis [138], even though
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counterregulatory hormone responses may be excessive, causing blood gluc-
ose concentration to fall.
Whereas the decrease in blood glucose concentrations may be considered a be-
neficial effect during mild to moderate exercise of short duration, during more
vigorous or prolonged exercise, if no insulin-reduction dosage and/or sup-
plemental carbohydrate feedings before and during exercise are considered,
hypoglycemia may occur. In fact, it is a well-established clinical reality that
physical activity influences glucose concentrations in T1DM patients not only
during exercise but also several hours postexercise leading to late evening and
nocturnal hypoglycemia [63, 83]. Different types of exercise (resistance vs.
aerobic) have contrasting effects on the duration and severity of acute [137]
and delayed [135] postexercise hypoglycemia. A recent review [9] has iden-
tified the importance of exercise as a major hurdle in the current standard
closed-loop control (CLC) efforts. While there is sufficient evidence to re-
commend physical activity in the management of T1DM [22], the duration,
intensity and form of exercise that should be recommended and whether
such interventions would translate to better outcomes are presently unclear.
A recent meta-analysis [117] suggests benefits of regular aerobic training,
interspersed with brief bouts of sprinting on glycated haemoglobin concen-
trations and incidence of delayed hypoglycemia in T1DM.
In contrast, opposite effects on glucose regulation during exercise in T1DM
subjects may also occur when exercise is undertaken during an insulin-deficient
state exacerbating hyperglycemia and promoting ketosis [5].
In general T1DM patients, in order to avoid hyperglycemic and hypoglycemic
events, are recommended to take some precautions when exercise is per-
formed: if blood glucose is greater than 250 mg/dL and ketones are present
in urine or blood, exercise should be postponed and the individual should
take supplemental insulin to reestablish good metabolic control; likewise, if
blood glucose is lower than 100 mg/dL and the individual has taken insulin
within the past 60 − 90 min, supplemental feedings should be taken before
and during exercise to avoid hypoglycemia. However, recently, research have
been focused on the therapeutic approaches to mitigate hypoglycemia during
and after physical activity in T1DM [41, 100, 102, 136].
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Exercise in type 2 diabetes
Type 2 diabetes is characterized by insulin resistance and impaired in-
sulin secretion, thus the major aim of T2DM therapy is to compensate these
states through an appropriate use of drugs, diet and exercise.
Exercise has long been advocated as beneficial in T2DM, partially because,
even in the face of insulin resistance, it can stimulate glucose uptake thus
resulting in a lower glycosylated haemoglobin concentrations and maybe an
improved insulin sensitivity. In fact, with onset of exercise, peripheral gluc-
ose utilization increases normally, but plasma insulin concentrations fail to
decline inducing blood glucose concentrations to fall toward normal but not
to hypoglycemic levels [87]. Thus, the risk of exercise-induced hypoglycemia
is prevented during mild to moderate exercise in T2DM who are not being
treated with insulin or sulfonylureas. In fact, these treatments can cause a
higher than normal insulin concentration during exercise which may suffi-
ciently inhibit hepatic glucose production to result in hypoglycemia.
In general, a regular exercise program can be an important part of a treat-
ment regimen for T2DM potentiating the effects of diet or drugs therapy to
lower glucose levels and improve insulin sensitivity [73].

3
Database & Protocol
3.1 Introduction
In this Chapter the experimental protocol used for the estimation of
postprandial glucose fluxes, quantification of insulin sensitivity and model-
ing glucose kinetics during physical activity in healthy subjects is described
in detail. The triple tracer approach, a validated technique able to minim-
ize fluctuations in tracer-to-tracee ratio enabling accurate measurement of
glucose turnover, is here used to assess postprandial glucose fluxes during a
session of physical activity. Moreover, plasma glucose and insulin concentra-
tion data and glucose fluxes are used to quantify the effect size of physical
activity on insulin sensitivity and to model its effect on glucose-insulin dy-
namics.
3.2 Research Design and Methods
3.2.1 Subjects
The study cohort is composed of 12 healthy individuals, 5 males and
7 females, age 37.1 ± 3.1 yr, body mass index 24.1 ± 1.1 kg/m2, fat-free
mass 50.9 ± 3.9 kg with normal fasting glucose and standard 75 grams oral
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glucose tolerance test (OGTT), and normal gastric emptying to solids and li-
quids. Exclusion criteria were significant gastrointestinal symptoms by ques-
tionnaire, documented recent upper gastrointestinal disorder, medications
affecting gastric motility (e.g., erythromycin), pregnancy or breast feeding,
or other comorbidities precluding participation. Medications (except stable
thyroid hormone or hormone replacement therapy) that could influence gluc-
ose tolerance, history of diabetes in first degree family members or prior
history of diabetes were also exclusionary. Subjects did not engage in vigor-
ous physical activities for 72 h prior to screen and study visits. Each subject
underwent two screen visits.
3.2.2 Screening visits
Visit 1
Subjects reported in the morning after an overnight fast to the Clin-
ical Research Unit (CRU) of the Mayo Center for Translational Science
Activities for a history, physical examination, screening laboratory tests,
a 75-gram standard OGTT, standard urinalysis and resting ECG. All wo-
men of childbearing potential had a negative pregnancy test within 24 h of
study visit. A dietary history was taken to ensure adherence to a weight-
maintaining diet consisting of at least 200 grams of carbohydrates/day and
that diet met American Diabetes Association guidelines for protein, fat and
carbohydrates. Body composition was also measured using dual-energy X-
ray absorptiometry [103]. After completion of the OGTT, participants per-
formed a graded exercise test on a treadmill to determine V˙O2max according
to guidelines (American College of Sports Medicine Guidelines for Exercise
Testing and Prescription, 7th Edition) and ensure stable cardiac status. Ex-
pired gases were collected and analyzed using indirect calorimetry. V˙O2max
was determined when at least two of three criteria were met: 1) Participant
too tired to continue exercise, 2) respiratory exchange ratio exceeded 1.0; 3)
a plateau was reached in oxygen consumption with increasing workload. The
purpose of this test was to use individual V˙O2max data to determine workload
during the moderate intensity (∼50% of V˙O2max) protocol during the study
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day.
Visit 2
Using established scintigraphic techniques (5), gastric emptying of solids
and liquids were assessed in all subjects who were eligible after the first
screening visit; results were summarized as the time required for 50% of
solids and separately liquids to empty. Thereafter, subjects who had normal
gastric emptying for solids and liquids proceeded to the inpatient study visit
within 3 wk of the second screening visit.
3.2.3 Experimental design
All subjects spent ∼40 h in the CRU.
Day 1
Subjects were admitted to the CRU at ∼1600. A point-of-care urine
pregnancy test was performed where appropriate to ensure that the test
was negative before proceeding any further. Thereafter two Dexcom 7 plus
continuous glucose monitors (CGM) and a Modular Signal Recorder (MSR)
accelerometer (MSR Electronics GmbH, Seuzach, Switzerland) were placed
and maintained for the rest of the study period. They were then provided
a standard 10 kcal/kg meal (55% carbohydrate, 15% protein, and 30% fat)
consumed between 1700 and 1730. No additional food was provided until
the next morning. A heart rate monitor was also attached to capture heart
rate during the study. Intravenous cannula was inserted into a forearm vein
at ∼2000 for tracer infusion and periodic blood draws during the study day
the following morning.
Day 2
At ∼0400 (t = -180 ) a primed continuous infusion of [6, 6−2 H2]glucose
was started. At ∼0600, an intravenous cannula was inserted retrogradely
into a hand vein for periodic blood draws. The hand was placed in a heated
(55◦C) plexiglass box to enable drawing of arterialized-venous blood for gluc-
ose, glucose tracer and hormone analyses. At∼0700 (time = 0 ) a triple tracer
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mixed meal study was performed [4]. A mixed meal containing 75 grams of
glucose labeled with [1 −13 C]glucose (Jell-O) was consumed within 15 min
along with the rest of the mixed meal of egss and ham/steak. Simultan-
eously, an intravenous infusion of [6−3 H]glucose was started and continued
for the next 6 h (t = 360 ) at a variable rate to mimic the anticipated rate
of appearance of the ingested [1 −13 C]glucose contained within the meal.
Concurrently, the [6, 6 −2 H2]glucose infusion rate was varied to mimic the
anticipated rate of endogenous glucose production (EGP). The meal provided
∼33% of daily estimated calorie intake. Two hours (t = 120 ) following the
first bite, subjects stepped on a treadmill to exercise at moderate intensity
activity (∼50% of V˙O2max): i.e., four bouts of walking at 3-4 miles/h for 15
min with rest periods of 5 min between each walking bout: total duration 75
min. The workload during physical activity was continuously monitored by
heart rate responses and measurements of V˙O2 during exercise to maintain
target V˙O2max ∼50% exercise intensity. The [6, 6−2 H2]glucose infusion rate
was modified from the start of physical activity at t = 120 for the next 3 h to
mimic the anticipated changes in EGP during physical activity. To determine
the optimal [6, 6−2H2]glucose infusion rate necessary to minimize changes in
tracer/tracee concentration for determination of postprandial EGP, we ana-
lyzed data from the first 2 subjects and modified the tracer infusion rates
accordingly to minimize changes in tracer/tracee ratios. This procedure was
adopted to also optimize the [6−3H]glucose infusion rate to minimize changes
in [6−3 H]glucose/[1−13 C]glucose concentrations to enable accurate estima-
tion of meal glucose appearance. Blood was sampled at periodic intervals for
measurement of glucose, insulin, glucagon and C-peptide (Figure 3.1) and
tracers molar ratios and counts (Figure 3.2); while tracer/tracee concentra-
tions were calculated by the ratio between [6 −3 H]glucose/[1 −13 C]glucose
and [6, 6 −2 H2]glucose/endogenous glucose, respectively. CGM and accel-
erometer recordings were collected throughout the study period to monitor
interstitial fluid glucose and quantitate activity levels, respectively, as part
of another study. Following the last blood draw, all tracer infusions were
stopped and the hand vein cannula removed. Lunch at 1300 and dinner at
1900 were provided, each meal contributing 33% of daily estimated caloric
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Figure 3.1: Glucose (top-left), insulin (top-right), glucagon (bottom-left) and
C-peptide (bottom-right) concentrations obtained from t = -180 to t = 360 min.
Shaded box between t = 120 and t = 195 min represents the exercise period at
50% V˙O2max.
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intake and having similar macronutrient composition as the breakfast meal.
From 1500 until 2200, subjects were asked to walk at 1.2 miles/h on the
treadmill for 26.5 min in 1 h, ie., 26.5 min on, 33.5 min off with time off
during dinner at 1900. This activity represents low grade activity levels that
mimic activities of daily living (ADL) [82]. The continuation of the study
for the rest of the day and overnight, including use of the CGM and accel-
erometer data, was part of additional investigation that is being currently
analyzed for future reporting.
Day 3
Basal resting metabolic rate ws measured at ∼0630. After completion of
the study at 0800, all cannulas were removed, and subjects were dismissed
from the CRU.
3.2.4 Analytical techniques
Hormone analyses
C-Peptide was measured on the Cobas e411 (Roche Diagnostics, Indi-
anapolis, IN) using a 2-site electrochemiluminescence immunometric assay.
Insulin was measured by a two-site immunoenzymatic assay performed on
the DxI automated system (Beckman Instruments, Chaska, MN) and Glu-
cagon by a direct, double antibody radioimmunoassay (Linco Research, St.
Charles, MO) [103].
Glucose tracers
Plasma samples were placed on ice, centrifuged at 4◦C, separated, and
stored at 80◦C until assay. Plasma glucose concentration was measured
using a glucose oxidase method (YSI, Inc., Yellow Springs, OH). Plasma
[6−3H]glucose specific activity was measured by liquid scintillation counting.
Plasma enrichment of [1−13 C]glucose and [6, 6−2 H2]glucose were measured
using GCMS (Thermoquest, San Jose, CA) to simultaneously quantitate C-1
to C-2 and C-3 to C-6 fragments [103].
4
Estimation of Postprandial Glucose Fluxes
4.1 Introduction
In this Chapter the triple-tracer technique for the estimation of postpran-
dial glucose fluxes is introduced. The method allows to estimate postprandial
glucose fluxes in a model-independent way by infusing tracers in order to
minimize fluctuations in tracer-to-tracee ratio (TTR). However, since it is
almost impossible to realize a perfect clamp of the plasma TTR, the use of
models is necessary to compensate the non-steady-state errors. This requires
the estimation of derivatives both for TTR and glucose signals and, due
to ill-conditioning, derivatives calculation is generally solved via regularized
deconvolution.
4.2 The triple-tracer approach
The ability of an individual to dispose an oral glucose load is the res-
ult of three different processes: appearance in plasma of ingested glucose
(Ra meal), endogenous glucose production (EGP) and glucose disposal (Rd).
Dual-tracer methods have been largely used to assess these fluxes by em-
ploying two tracers, one mixed with ingested glucose and a second infused
intravenously, and calculating the systemic appearance rate of both ingested
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tracer and total (i.e., ingested and endogenously produced) glucose. Ra meal
is then calculated by multiplying the rate of appearance of ingested tracer by
specific activity (or tracer-to-tracee ratio if a stable tracer is used) of glucose
or carbohydrate contained in the meal. EGP is subsequently calculated by
subtracting Ra meal from total glucose rate of appearance (Ra). Finally gluc-
ose Rd is calculated by subtracting rate of change of plasma glucose mass
from Ra. However, as extensively discussed [1, 4, 78, 84, 116], the marked
tracer nonsteady state that occurs with the dual-tracer method introduces
errors and renders the calculation of Ra meal, EGP and Rd dependent on both
the model used in the calculation (e.g., one or two compartments) and its
parameters (e.g., the volume of distribution).
The triple-tracer technique [4] circumvents these problems, aiming to estim-
ate in a model-independent manner Ra meal and EGP fluxes by minimizing
changes in both meal and endogenous plasma TTR (Figure 4.1) thanks to
appropriate infusion of three tracers. Changes in the plasma ratios of the
intravenous and ingested tracers were minimized by intravenously infusing
[6 −3 H]glucose to mimic the systemic Ra meal of the [1 −13 C]glucose con-
tained in a mixed meal. At the same time, changes in the ratio between
[6, 6−2H2]glucose tracer and endogenous glucose were minimized by infusing
[6, 6−2H2]glucose mimicking the anticipated pattern of change of EGP. How-
ever, this is a circular logic, i.e. tracers infusion is appropriately modified in
order to reproduce the unknown pattern. Thus, one can at least to minimize
the change in TTR, by adjusting tracers infusion rate based on pilot studies.
Let now define some variable useful for the following calculations:
• Tracee: glucose at natural composition, coming from ingested glucose
and EGP.
• TracerI : [1−13C]glucose tracer above natural ingested during the meal.
• TracerII : [6, 6 −2 H2]glucose tracer infused intravenously, consisting
primarly of [6, 6−2 H2]glucose (tracer purity is 94%), a minor amount
of [6, 6−2H1−1H1]glucose and a negligible amount of [6, 6−1H2]glucose.
• TracerIII : [6−3 H]glucose tracer infused intravenously.
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Figure 4.1: Study design of tracers infusion. Adapted from [4].
• Gnat: concentration of tracee in plasma [mg/dL].
• G13C : concentration of tracerI in plasma [mg/dL].
• G2H : concentration of tracerII in plasma [mg/dL].
• G3H : concentration of tracerIII in plasma [dpm/mL].
• F2H : rate of intravenous infusion of tracerII [mg/min].
• F3H : rate of intravenous infusion of tracerIII [dpm/min].
26 Estimation of Postprandial Glucose Fluxes
• G : plasma glucose concentration measured in the arterialized hand vein
samples [mg/dL].
First of all, in order to derive the formulas for calculating glucose fluxes,
tracer and tracee glucose concentrations in plasma are calculated:
• MR13C is the ratio of [1 −13 C]glucose to [1 −12 C]glucose in plasma.
MR13C above natural, i.e. corrected for natural abundance of all atoms,
is related to tracerI, tracerII and tracee by the following formula
MR13C −MR13C,nat =
tracerI
tracee+ tracerII
· (1 +MR13C,nat)
=
G13C
Gnat +G2H
· (1 +MR13C,nat)
(4.1)
where MR13C,nat represents the ratio between
13C and 12C in natural
glucose, equal to 0.011.
• MR2H is the ratio of [6, 6−2 H2]glucose to [6, 6−1 H2]glucose in plasma
corrected for natural abundance. It quantifies 94% of tracerII divided
by tracee plus tracerI
MR2H =
tracerII
tracee+ tracerI
=
G2H · 0.94
Gnat +G13C
(4.2)
Total plasma glucose concentration (G) measures the sum of the concentra-
tion of tracee, tracerI and tracerII in plasma
G = Gnat +G13C +G2H (4.3)
From Eqs. 4.1, 4.2 and 4.3, G13C , G2H and Gnat can be obtained as
G13C =
MR13C −MR13C,nat
1 +MR13C
·G (4.4)
G2H =
0.94
MR2H −MR2H
·G (4.5)
Gnat = G−G13C −G2H (4.6)
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The concentration of plasma glucose derived from EGP (Gend) can be calcu-
lated by subtracting from the total plasma glucose concentration (Gnat) the
ingested natural glucose, which is related to G13C through the ratio between
tracerI and natural glucose in the meal (ttrmeal) obtained as
Gend = Gnat −G13C/ttrmeal (4.7)
Assuming a perfect clamp of the plasma TTR of G3H-to-G13C (i.e. vari-
ations are negligible), Ra 13C equals the infusion rate of the tracer (i.e. [6−3
H]glucose) divided by the plasma TTR (G3H-to-G13C ratio)
Ra 13C =
F3H
G3H/G13C
(4.8)
Then Ra meal is calculated as
Ra meal = Ra 13C ·
(tracee+ tracerI
tracerI
)
meal
= Ra 13C ·
( 1
ttrmeal
+ 1
)
(4.9)
Similarly, assuming a perfect clamp of the plasma TTR of G2H-to-Gend,
EGP is calculated as
EGP =
F2H
G2H/Gend
(4.10)
Although the estimation of Ra meal and EGP is virtually model independent,
the calculation of Rd requires to use a model.
4.3 Models for fluxes estimation
Since it is almost impossible to realize a perfect clamp of the plasma
TTR, the use of models is necessary to compensate the non-steady-state
errors and, as stated in the previous Section, they are fundamental for the
estimation of Rd. In this Section, two compartmental models (i.e., single-
compartment and two-compartment) for the calculation of unknown glucose
fluxes are presented.
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4.3.1 Single-compartment model
This model is based on a single-compartment description of the system
and was introduced in [108, 109]. The model assumes that Ra and Rd of
glucose and glucose tracers take place in the accessible compartment, which
has a volume equal to a fraction p (pool fraction) of the total glucose dis-
tribution volume V fixed to population values. Mass balance equation of
[6−3 H]glucose is then
pV · dG3H
dt
= F3H −Rd 3H (4.11)
where G3H is the concentration of [6−3H]glucose tracer in plasma, F3H is the
rate of [6−3 H]glucose infusion and Rd3H is the rate of [6−3 H]glucose tracer
disappearance in plasma. Similarly, for the [1−13 C]glucose tracer
pV · dG13C
dt
= Ra 13C −Rd 13C (4.12)
where G13C is the concentration of [1 −13 C]glucose tracer in plasma, Ra3H
and Rd13C are, respectively, the rate of [1−13 C]glucose tracer apperance and
disappearance in plasma.
Isotopic indistinguishability allows one to link the disappearance rate of the
two tracers to their amount in the accessible compartment
Rd 3H
pV G3H
=
Rd 13C
pV G13C
= k01 (4.13)
where k01 is the disappearance rate parameter, which is assumed to vary
during the experiment.
By using Eq. 4.13, Eqs. 4.11 and 4.12 can be rewritten as
pV · dG3H
dt
= F3H − k01pV G3H (4.14)
pV · dG13C
dt
= Ra 13C − k01pV G13C (4.15)
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From the [6 −3 H]glucose mass balance equation (Eq. 4.14), an expression
for the disappearance rate parameter k01 of [6−3 H]glucose tracer (k01,3H) is
derived
k01,3H = −
dG3H/dt
G3H
+
F3H
pV G3H
(4.16)
By using equation Eq. 4.16 into Eq. 4.15, one obtains
Ra 13C =
F3H
G3H/G13C
− pV G13C
G3H/G13C
· d(G3H/G13C )
dt
(4.17)
By applying the same rationale to [6, 6−2H2]glucose and endogenous glucose,
an expression for the disappearance rate parameter k01 of [6, 6−2 H2]glucose
tracer (k01,2H) is derived
k01,2H = −
dG2H/dt
G2H
+
F2H
pV G2H
(4.18)
By using Eq. 4.18 into endogenous glucose (Gend) mass balance equation,
one obtains
EGP =
F2H
G2H/Gend
− pV Gend
G2H/Gend
· d(G2H/Gend)
dt
(4.19)
Finally, since Ra meal is calculated by using Eq. 4.9, Rd results
Rd =
(
Ra meal + EGP + F2H
)− pV dG
dt
(4.20)
4.3.2 Two-compartment model
This model is based on a two-compartment description of the system and
was introduced in [93]. The model assumes exchange between the accessible
and remote compartments and irreversible loss from the accessible compart-
ment only, which has a volume equal to V1 fixed to population value. Mass
balance equation of [6 −3 H]- and [1 −13 C]glucose tracers in the accessible
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compartment are
V1 · dG3H
dt
= F3H −
(
R01,3H +R21,3H
)
+R12,3H (4.21)
V1 · dG13C
dt
= F13C −
(
R01,13C +R21,13C
)
+R12,13C (4.22)
where R01,3H and R01,13C denote the irreversible flux of the two tracers from
the accessible compartment and R12,3H , R21,3H , R21,13C and R21,13C are ex-
change fluxes.
Isotopic indistinguishability provides
R01,3H
V1G3H
=
R01,13C
V1G13C
= k01
R21,3H
V1G3H
=
R21,13C
V1G13C
= k21
R12,3H
V2G3H
=
R12,13C
V2G13C
= k12
(4.23)
The model assumes that parameters k12 and k21 remain constant and are
fixed to population values while k01 varies during the experiment. By using
Eq. 4.23, Eqs. 4.21 and 4.22 can be rewritten as
V1 · dG3H
dt
= F3H − (k01 + k21)V1G3H + k12Q2,3H (4.24)
V1 · dG13C
dt
= F13C − (k01 + k21)V1G13C + k12Q2,13C (4.25)
where Q2,13C and Q2,3H are the amounts of [1−13C]glucose and [6−3H]glucose
tracer in the peripheral compartment. From the [6−3H]glucose mass balance
equation (Eq. 4.24), an expression for the disappearance rate parameter k01
of [6−3 H]glucose tracer (k01,3H) is derived
k01,3H = −
dG3H/dt
G3H
+
F3H
V1G3H
− k21 + k12Q2,3H
V1G3H
(4.26)
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By using Eq. 4.26 into Eq. 4.25, one obtains
Ra 13C =
F3H
G3H/G13C
− V1G13C
G3H/G13C
· d(G3H/G13C )
dt
+ k12
( Q2,3H
G3H/G13C
−Q2,13C
)
(4.27)
As result, Ra 13C is expressed as a function of known (F3H , V1, k12) or meas-
ured (G3H , G13C) variables but also of Q2,13C and Q2,3H , which are not meas-
ured. These last variables were evaluated by solving the mass balance equa-
tions of the [6−3 H]- and [1−13 C]glucose tracers in the peripheral compart-
ment
dQ2,3H
dt
= −k12Q2,3H + k21V1G3H (4.28)
dQ2,13C
dt
= −k12Q2,13C + k21V1G13C (4.29)
By applying the same rationale to [6, 6−2H2]glucose and endogenous glucose,
an expression for the disappearance rate parameter k01 of [6, 6−2 H2]glucose
tracer (k01,2H) is derived
k01,2H = −
dG2H/dt
G2H
+
F2H
V1G2H
− k21 + k12Q2,2H
V1G2H
(4.30)
By using Eq. 4.30 into endogenous glucose (Gend) mass balance equation,
one obtains
EGP =
F2H
G2H/Gend
− V1Gend
G2H/Gend
· d(G2H/Gend)
dt
+ k12
( Q2,2H
G2H/Gend
−Q2,end
)
(4.31)
where Q2,2H and Q2,end are the amounts of [6, 6 −2 H2]glucose tracer and
endogenous glucose in the peripheral compartment, evaluated by solving the
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mass balance equations
dQ2,2H
dt
= −k12Q2,2H + k21V1G2H (4.32)
dQ2,end
dt
= −k12Q2,end + k21V1Gend (4.33)
Finally, since Ra meal is calculated by using Eq. 4.9, Rd results
Rd =
(
Ra meal + EGP + F2H
)− V1dG
dt
− k21V1G+ k12Q2 (4.34)
where Q2 is the amount of glucose in the peripheral compartment to be
evaluated by integrating model equations.
4.4 Data smoothing and derivative calculation
As reported in the previous Section, the use of models for calculating
Ra meal and EGP, accounting for non-steady-state errors in TTR (Eqs. 4.17,
4.19 and Eqs. 4.27, 4.31), and Rd, accounting for changing in glucose con-
centration (Eq. 4.20 and Eq. 4.34), needs derivatives calculation. However,
since TTR and glucose signals are affected by noise, derivatives calculation
cannot be straightforwardly solved due to amplification of the measurement
errors.
Traditional methods evaluate time derivatives using a two-step process, i.e.
data are first smoothed, then a numerical estimation of the time derivatives
is performed. In fact, TTR and glucose signals y(t) can be modeled as
y(t) = z(t) + v(t) (4.35)
where z(t) is the real unknown input signal and v(t) the measurement error,
that can be assumed to be a random white noise process with zero mean
and unknown variance, possibly varying with time. Direct estimation of
the first derivative of a signal via finite differences is often not satisfactory
and the resulting signal is noisy, since differentiation acts as a high-pass
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filter amplifying high frequency measurement noise. Thus, several literature
approaches can be used to obtain a smoothed version of the of the signal
z(t), e.g. Moving Average filters [54]. Such filters are not adaptive, i.e. their
parameters remain the same throughout the monitoring and do not efficiently
exploit available a priori statistical information in both the regularity of
the signal and measurement error. This is why, in this thesis, a Bayesian
approach [56] to simultaneously perform both data smoothing and derivative
calculations is used.
The problem of estimating the time-derivative u(t) can be considered as a
deconvolution problem [36], i.e. defining u(t) such that u(t) = z˙(t) where,
for a generic time instant t0, it holds
z(t) = z(t0) +
∫ t
t0
u(τ)dτ (4.36)
Assuming for simplicity t0 = 0 and z0 = 0, one obtains
z(t) =
∫ t
0
g(t− τ)u(τ)dτ = g(t)⊗ u(t) (4.37)
where
g(t) = 1(t) =
0 if t < 01 if t > 0 (4.38)
The problem can be discretized by integrating g(t) over the time intervals
where u(t) is assumed to be constant. The model of data is defined as
y = Gu+ v (4.39)
where G is the integrator in the matrix-vector representation
G =

1 0 . . . . . . 0
1 1 0 . . . 0
1 1 1 . . . 0
...
...
...
. . .
...
1 . . . . . . . . . 1

(4.40)
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In a Bayesian framework, i.e. u, v and y are considered as stochastic variables,
the estimate of u given by y and the model 4.39 can be tackled as a minimum
error variance estimate. The solution of this problem coincides with that of
determining the vector uˆ which minimizes the expected value of the quadratic
norm of the estimate error
E
[
||u− uˆ||2
]
(4.41)
Restricting the search into the class of linear estimators, it can be demon-
strated that, if u and v are uncorrelated, have zero mean and known covari-
ance matrices Σu and Σv respectively, the best linear estimate of u given y
is the solution of the following optimization problem
min
uˆ
(y −Guˆ)TΣ−1v (y −Guˆ) + uˆTΣ−1u uˆ (4.42)
Notably, the argument of the minimization problem is made of two terms:
• (y − Guˆ)TΣ−1v (y − Guˆ) represents the adherence of the model to the
data, i.e. it accounts for the posterior information yielded by the data.
• uˆTΣ−1u uˆ represents the adherence of the unknown vector u to the prior
information available on u itself.
Eq. 4.42 has a closed form solution given by
uˆ = (GTΣ−1v G+ Σ
−1
u )
−1GTΣ−1v y (4.43)
In order to solve the minimization problem, it is necessary to have a second-
order a priori statistical description of vectors u and v.
For TTR and glucose signals, we can assume the following models for the
statistical a priori knowledge:
• Second order statistical description of vector v : covariance matrix of
vector v described as
Σv = σ
2B (4.44)
with B known matrix and σ2 scaling factor, possibly unknown.
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• Second order statistical description of vector u: for biological signals,
the a priori information on the signal to be estimated are qualitative,
i.e. the signal is assumed to be smooth and regular. Formally, this
can be described considering the components of the vector u(t) to be
the realization of a stochastic process that is modeled by a cascade
of m integrators driven by a white noise process with zero mean and,
possibly, time-varying statistics. Prior covariance matrix is described
as
Σu = F
−1ΛF−T with F = ∆m (4.45)
where m represents the penalty index of the m-th order derivatives of
u(t), ∆ is the lower-triangular Toeplitz matrix
∆ =

1 0 0 . . . 0 0
−1 1 0 . . . 0 0
0 −1 1 . . . 0 0
...
...
. . . . . .
...
...
...
...
... −1 1 0
0 . . . . . . 0 −1 1

(4.46)
and Λ is a diagonal matrix representing statistics properties of the white
noise process (described below). Eq. 4.45 can be represented as
Σu = λ
2(QTQ)−1 with Q = Ω−1F (4.47)
where Ω is given by Λ = λ2(ΩΩT ) and λ2 is a scale factor.
Assuming to have a statistical description of the covariance matrices as
defined in Eqs. 4.44 and 4.47, Eq. 4.42 can be rewritten as
uˆ = (GTB−1G+ γ0QTQ)−1GTB−1y (4.48)
The ratio γ0 = σ2/λ2 determines the best trade-off between the adherence to
the prior and the data. The Bayesian framework allows to optimally weight
the relative importance of the prior and of the data, since the statistical
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knowledge on their variance is explicitly considered in the computation of
the estimate. Considering the problem defined in Eq. 4.41 and its closed
form solution in Eq. 4.48, two quantities can be defined
• WRSS : Weighted Residuals Sum of Squares
WRSS = (y −Guˆ)TB−1(y −Guˆ) (4.49)
• WESS : Weighted Estimates Sum of Squares
WESS = uˆTQTQuˆ (4.50)
In a stochastic framework, WRSS and WESS are random variables, whose
realizations depend on the value of γ. It can be shown [36] that for the
optimal value of γ0, the following properties hold
E
[
WESS(γ0)
]
= λ2 · q(γ0) (4.51)
E
[
WRSS(γ0)
]
= σ2{n− q(γ0)} (4.52)
where
q(γ0) = trace[B−1/2G(GTB−1G+ γ0QTQ)−1GTB−1/2] (4.53)
withB−1/2 is a square matrix such thatB−1 = B−1/2B−1/2. Some consistency
criteria can be defined from the properties expressed in Eqs. 4.51 and 4.52
for the choice of the best γ in conditions where σ2, λ2 or both are unknown.
In particular
Consistency Criterion 1 : if λ2 is unknown but σ2 is known, choose γ
such that the following condition is matched
WESS(γ) = λ2 · q(γ0) with λ2 = σ2/γ (4.54)
Consistency Criterion 2 : if σ2 is unknown but λ2 is known, choose γ
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such that the following condition is matched
WRSS(γ) = σ2{n− q(γ0)} with σ2 = λ2 · γ (4.55)
Consistency Criterion 3 : when both σ2 and λ2 are unknown, choose γ
such that the following condition is matched
WRSS(γ)
n− q(γ) = γ ·
WESS(γ)
q(γ)
(4.56)
then, when γ is determined from Eq. 4.56, compute the posterior
estimate of σ2 from 4.49 as
σˆ2 =
WRSS
n− q(γ) (4.57)
Depending upon the statistical properties of the unknown input signal u, the
unknown input signal can be described a priori as multiple integrations of a
stationary or time-varying white noise process. Two descriptions of the prior
covariance matrix 4.47 are reported.
4.4.1 Standard stochastic deconvolution method
The standard approach is based on the hypothesis that the expectations
on the smoothness of the unknown input signal u can be formalized by de-
scribing it a priori as multiple integrations of a stationary white noise process.
This allow us to define Λ such that
Λ =

λ2 0 . . . . . . 0
0 λ2 0 . . . 0
0 0
. . . . . .
...
...
...
...
. . .
...
0 . . . . . . . . . λ2

= λ2 · I (4.58)
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where I is the identity matrix and λ2 represents the constant variance of the
stationary white noise process.
4.4.2 Improved stochastic deconvolution method
If the unknown input signal shows marked nonstationarity, the standard
formulation of the regularization approach in Section 4.4.1 cannot be ap-
plied. In [90], an improved stochastic deconvolution method, accounting for
nonstationarity in the unknown input signal, is showed. In this work, the
biphasic pattern of insulin secretion rate, after a glucose stimulus, consisting
of a spike followed by a more regular release, was modeled as a multiple integ-
ration of a white noise process with time-varying statistics. More specifically,
the white noise process is composed of two different variances: λ21 for t ≤ τ
for the first phase secretion, and λ22 for t > τ for the second phase secretion.
Thus matrix Σu is the same of Eq. 4.45 but, in this case, Λ is defined as
Λ =

λ21 0 . . . . . . 0
0 λ21 0 . . . 0
0 0 . . .
. . .
...
...
...
... λ22
...
0 . . . . . . . . . λ22

(4.59)
The three parameters λ21, λ
2
2 and τ have to be estimated from the data, y,
together with the input profile and with the parameter σ2 which represents
the variance of the measurement error. To solve the problem of finding these
unknown parameters, in [90] a set of possible values of τ and of the ratio
λ21/λ
2
2 is defined and the best combination of λ
2
1, λ
2
2, σ
2 and τ is selected,
which maximizes the likelihood function L of y. The choice λ21/λ
2
2 and τ
fixed permits to employ the same fast algorithm proposed in [36] where only
one regularization parameter was considered in the problem.
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General problem
In general, if a priori information on the time-varying statistics of the
input signal are unknown, one can build the matrix in Eq. 4.59 by assuming
k different variances of the white noise process, thus obtaining
Λ =

λ21 0 . . . . . . . . . . . . 0
0 λ21 . . . . . . . . . . . .
...
...
... . . .
. . .
...
...
...
...
...
... λ22
...
...
...
...
...
...
... . . .
...
...
...
...
...
...
... λ2k 0
0 . . . . . . . . . . . . 0 λ2k

(4.60)
The definition of k different variances of the white noise process implies
the definition of k− 1 values for τ , representing the times of variation of the
white noise process statistics, and reformatting Eq. 4.60 dividing by λ21 one
obtains
Λ = λ21

1 0 . . . . . . . . . . . . 0
0 1 . . . . . . . . . . . .
...
...
... . . .
. . .
...
...
...
...
...
... λ
2
2
λ21
...
...
...
...
...
...
... . . .
...
...
...
...
...
...
... λ
2
k
λ21
0
0 . . . . . . . . . . . . 0
λ2k
λ21

(4.61)
Then, defining α2j = λ
2
j+1/λ
2
1 with j = 1, . . . , k − 1 as the ratio between
the variances of the white noise and λ21, one has
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Λ = λ21

1 0 . . . . . . . . . . . . 0
0 1 . . . . . . . . . . . .
...
...
... . . .
. . .
...
...
...
...
...
... α21
...
...
...
...
...
...
... . . .
...
...
...
...
...
...
... α2k−1 0
0 . . . . . . . . . . . . 0 α2k−1

= λ21(ΩΩ
T ) (4.62)
where Ω was previously defined in Eq. 4.47. Eq. 4.62 allows us to resort to
the same algorithm proposed in [90] by fixing a set of possible values for τ
and α2.
Specific problem
Focusing on the present specific problem, since the priori information on
time-varying statistics of the input signal due to physical activity is unknown,
we hypothesized such a matrix Λ as
Λ =

λ21 0 . . . . . . . . . . . . . . . . . . 0
0
. . . . . . . . . . . . . . . . . . . . .
...
...
... λ21
. . .
...
... . . . . . .
...
...
...
... λ22
...
... . . . . . .
...
...
...
...
...
. . .
... . . . . . .
...
...
...
...
...
... λ22 . . . . . .
...
... . . . . . . . . . . . . . . . λ23 . . .
...
... . . . . . . . . . . . . . . . . . .
. . . 0
0 . . . . . . . . . . . . . . . . . . 0 λ23

(4.63)
where, in Eq. 4.63, three different variances of the white noise process are
assumed:
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• λ21, i.e. meal phase, starting at t = 0 min and lasting till the start of
the physical activity session at t = 120 min.
• λ22, i.e. exercise phase, starting at t = 120 min and lasting till t = τ
min with τ to be estimated, where physical activity effect is assumed
to begin sufficiently soon, as can be observed by the rapid falling, on
average, of plasma glucose signal (Figure 3.1, top-left).
• λ23, i.e. recovery phase, starting at t = τ min and lasting till the end of
the experiment at t = 360 min.
Thus, four parameters λ21, λ
2
2, λ
2
3 and τ have to be estimated from the data.
Applying the same rationale used in [90], we can reformulate the problem
defining α21 =
λ22/λ21 and α
2
2 =
λ23/λ21 in order to rewrite Eq. 4.63 as
Λ = λ21

1 0 . . . . . . . . . . . . . . . . . . 0
0
. . . . . . . . . . . . . . . . . . . . .
...
...
... 1
. . .
...
... . . . . . .
...
...
...
... α21
...
... . . . . . .
...
...
...
...
...
. . .
... . . . . . .
...
...
...
...
...
... α21 . . . . . .
...
... . . . . . . . . . . . . . . . α22 . . .
...
... . . . . . . . . . . . . . . . . . .
. . . 0
0 . . . . . . . . . . . . . . . . . . 0 α22

(4.64)
To solve the problem of finding these unknown parameters a set of possible
values for the following parameters was assumed:
• α21 and α22 were assumed to vary, on average, between 10−2 to 102, where
lower values represent less variability while higher values represent high
variability of the white noise process.
• τ was assumed to vary from the start of physical activity (t = 120), i.e.
no effect of physical activity, to the end of physical activity (t = 195),
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i.e. for the entire duration of physical activity session, with the same
time step of the sampling grid.
The choice of fixing parameters to a limited, but sufficiently large, set of
possible values allows us to resort the same fast algorithm proposed in [36],
where only one regularization parameter was considered in the problem at
each step and to repeat the search to all possible values. Finally, the method
proposed in [90] suggests to select the best combination of parameters (α21,
α22 and τ) which maximizes the likelihood function L of the data.
Moreover, in addition to the method proposed in [90] for the choice of
optimal combination of parameters, in this study, a new criterion is proposed.
This new method is based on the statistical properties of weighted residuals
of the deconvolution technique. As a matter of fact, assuming measurement
error to be a white gaussian noise with zero-mean and possibly unknown vari-
ance, weighted residuals should be an approximation of measurement errors
normalized to their standard deviation (possibly unknown), i.e. a realization
of a random process having unit variance. The aim is to satisfy all these
hypothesis and minimize the objective function WRSS + γ ·WESS, where
the regularization parameter γ is estimated from the data and represents the
best trade-off between the adherence to the data and the a priori information.
The use of the objective function above may help in choosing the optimal
combination of parameters in the case of similar statistical characteristics of
weighted residuals. Then two indices to be maximized, one for TTR and one
for glucose signals, are obtained:
• TTR: the optimal combination of parameters for TTR signal is ob-
tained by maximizing
p(t-test) · p(runs-test) · p(KS-test)
WRSS + γ ·WESS (4.65)
where in the numerator one can find the p-value of 3 statistical tests,
i.e. Student's t-test (p(t-test)), Wald-Wolfowitz runs test (p(runs-test)) and
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Kolmogorov-Smirnov test (p(KS-test)) in order to respectively quantify
the zero-mean, randomness and normality of the distribution of weighted
residuals, and in the denominator the objective function WRSS + γ ·
WESS.
• Glucose: the optimal combination of parameters for glucose signal is
obtained by maximizing
p(t-test) · p(runs-test) · p(KS-test) · p(χ2-test)
WRSS + γ ·WESS (4.66)
in this case in the numerator, at variance with the index obtained for
the TTR signal, also the Chi-square test for the variance (p(χ2-test)) is
used since, for glucose signal, the variance is a priori known. This test
is not used for TTR signal in order not to overestimate the effect of the
variance on the smoothing procedure of TTR data since it is already
estimated from the data.
4.5 Results
Data are presented as mean ± SE, if not differently indicated. Rates of
glucose turnover are expressed as milligrams per kilogram of body weight per
minute. Postprandial glucose fluxes were averaged on a total of 11 subjects,
since an error on the measurement of meal enrichment was reported in one
subject. Values obtained at t = 0 min were considered as basal. In the
following Figures, shaded box between t = 120 and t = 195 min represents
the exercise period at 50% V˙O2max.
4.5.1 Plasma glucose, hormones and tracers data
In Figure 3.1 plasma glucose, insulin, C-peptide and glucagon concentra-
tion data are reported. Plasma glucose concentration rose from baseline of
89.6 ± 3.24 mg/dL to a peak of 164.6 ± 10.45 mg/dL at t = 60 min, then
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dropped to 112.7 ± 10.64 mg/dL at t = 120 min (start of exercise), and
reached a nadir of 71.6 ± 5.03 mg/dL at t = 140 min. Thereafter, plasma
glucose concentration gradually rose to 78.0±2.70 mg/dL at t = 195 min (end
of exercise) before returning to baseline 89.7 ± 2.81 mg/dL at t = 250 min,
remaining constant thereafter until t = 360 min. Plasma insulin concentra-
tion rose from baseline of 3.7± 0.61 µU/mL to a peak of 54.1± 6.81 µU/mL
at t = 60 min, then dropped to 32.8± 6.78 µU/mL at t = 120 min (start of
exercise), and reached a nadir of 4.9±1.14 µU/mL at t = 195 min (end of ex-
ercise) before gradually drifting to 4.5±1.41 µU/mL at t = 360 min. Plasma
C-peptide concentration rose from a baseline of 0.55±0.05 nmol/L to a peak
of 3.46± 0.32 nmol/L at t = 90 min, then dropped to 2.88± 0.36 nmol/L at
t = 120 min (start of exercise), and reached 0.88 ± 0.11 nmol/L at t = 195
min (end of exercise) before gradually drifting down to 0.58 ± 0.08 nmol/L
at t = 360 min. In contrast, plasma glucagon concentration at baseline were
59.3±4.49 pg/mL, then briefly rose on meal ingestion before falling to a nadir
of 54.3 ± 4.19 pg/mL at t = 60 min, then slowly rose to 64.0 ± 7.41 pg/mL
at t = 120 min (start of exercise) before rapidly rising more than two-fold
to a peak of 135 ± 18.85 pg/mL at t = 180 min. Subsequently, glucagon
concentration rapidly fell to 70.9± 6.89 pg/mL at t = 360 min.
In Figure 3.2 [1−13 C] MR above natural, [6, 6−2 H2] MR and [6−3 H] gluc-
ose counts data are reported. [1 −13 C] MR above natural rose to a peak
of 3.34 ± 0.09% at t = 120 min after meal ingestion and then declined to
0.89 ± 0.13% at the end of the experiment. [6, 6 −2 H2] MR declined from
baseline of 4.47± 0.23% to a plateau of approximately 0.82± 0.06% between
t = 120 and t = 150 min, then increased to 3.00 ± 0.15% at the end of the
experiment. [6−3H] glucose counts rose to a peak of 1728.7±181.09 dpm/mL
at t = 60 min and then decreased to 425.0 ± 27.33 dpm/mL at the end of
the experiment.
Then, starting from plasma glucose (Figure 3.1, top-left), molar ratios
and counts data (Figure 3.2), glucose tracers concentration G13C , G3H , G2H
and endogenous glucose Gend are calculated (Figure 4.2) by using Eqs. 4.4,
4.5 and 4.7. As can be observed in Figure 4.2, on average, profiles of G13C
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Figure 4.2: [1 −13 C]glucose (top-left), [6 −3 H]glucose (top-right), [6, 6 −2
H2]glucose (bottom-left) and endogenous glucose (bottom-right) concentrations
calculated from t = 0 and t = 360 min.
to G3H and G2H to Gend are very similar, respectively, thus indicating a good
clamp of the respective tracer-to-tracee ratios. However, this may not always
be the case for individual signals, since, as previously remarked, it is almost
impossible to realize a perfect clamp of the plasma TTR. In fact, usually
it may happen that:
• [6 −3 H]glucose-to-[1 −13 C]glucose ratio shows, especially in the ini-
tial few minutes after meal ingestion, unavailable measurements (either
G13C or G3H below the limit of detection) or very high values and of
uncertain reliability, as indicated by an error propagation analysis.
• [6, 6−2 H2]glucose-to-endogenous glucose ratio shows, especially in the
endogenous glucose suppression phase, very high or even negative val-
ues due to very low or negative values, respectively, of endogenous
glucose concentration. This can be due to measurement error on both
tracer and tracee data from which Gend is derived (Eq. 4.7).
Thus, when the above described events occur, we are required to exclude
these measurements, in one hand, to eliminate unacceptable values of TTR
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and, on the other hand, to avoid errors on derivative calculation.
Then, starting from glucose tracers concentration G13C , G3H , G2H and
endogenous glucose Gend we can calculate tracer-to-tracee ratios (Figure 4.3)
as
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Figure 4.3: [6−3H]glucose-to-[1−13C]glucose ratio (top) and [6, 6−2H2]glucose-
to-endogenous glucose ratio (bottom).
• G3H/G13C , called also specific activity (SA), where [6 −3 H]glucose
is considered as tracer while [1 −13 C]glucose is considered as tracee
(Figure 4.3, top). As can be observed, the ratio G3H/G13C is fairly
constant for almost the entire duration (t = 10 − 360 min) of the
study apart form the initial perturbation (t = 0 − 10 min) that is
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unavoidable, as previously explained, when the intravenously infused
and orally ingested tracee are entering the systemic circulation. In
contrast, physical activity starting at t = 120 min does not alter SA,
since the plasma concentrations of tracer and tracee changed in parallel
throughout the study.
• G2H/Gend where [6, 6−2 H2]glucose is considered as tracer while endo-
genous glucose is considered as tracee (Figure 4.3, bottom). As can be
observed, the ratio G2H/Gend is also fairly constant apart from a slight
fall at t = 120 min at the start of exercise. This nonstationary has to
be carefully taken into account when TTR derivative is calculated.
4.5.2 Methods for glucose fluxes estimation
As shown in Figure 4.3, it is almost impossible to realize a perfect clamp
of the plasma TTR. Thus postprandial glucose fluxes can be calculated using
either a single-compartment or a two-compartment model (1CM and 2CM,
respectively) to compensate the non-steady-state errors and to estimate Rd.
Model parameters are fixed to population values: V = 200 mL/kg and p =
0.65 for the one-compartment [109], while V1 = 130 mL/kg, k12 = 0.07 min−1
and k21 = 0.05 min−1 for the two-compartment [4, 93]. However the use of
models requires derivatives calculation for G3H/G13C , G2H/Gend and glucose
signals, here approached adopting a deconvolution technique. Two possible
implementations of the deconvolution technique have been considered, both
working in a Bayesian framework, but each assuming a particular statistical
property of the unknown input signal.
Standard stochastic deconvolution method
The standard stochastic deconvolution approach hypothesizes that the
expectations on the smoothness of the unknown input signal u can be form-
alized by describing it, a priori, as multiple integrations of a stationary white
noise process. For each signal, the same assumptions used in [4] have been
considered:
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• G3H/G13C : since the clamp of the SA is often a smooth signal, thanks to
pilot studies information and given the subjects' normal gastric empty-
ing, its derivative can be assumed as a realization of a stochastic pro-
cess modeled by a cascade of two integrators (m = 2) driven by a white
noise process with unknown constant variance (λ2), while measurement
error is assumed to be constant with unknown coefficient of variation
(σ2 = (CV · y)2).
• G2H/Gend: since the clamp of TTR is often more difficult to realize
due to the high variability of Gend, its derivative can be assumed as
a realization of a stochastic process modeled by an integrator (m =
1) driven by a white noise process with unknown constant variance
(λ2), while measurement error is assumed to be constant with unknown
coefficient of variation (σ2 = (CV · y)2).
• Glucose: glucose signal is known to be smooth and generally it is de-
scribed by an integrated random-walk model, thus its derivative can be
described as a realization of a stochastic process modeled by an integ-
rator (m = 1) driven by a white noise process with unknown constant
variance (λ2), while measurement error on glucose signal is generally
assumed to be constant with a known coefficient of variation equal to
2% (σ2 = (0.02 · y)2).
In Figure 4.4 average data vs. reconvolution (left) and weighted residuals
(right) of G3H/G13C , G2H/Gend and glucose signals obtained with the stand-
ard stochastic deconvolution method are showed. On top panels of Figure
4.4 and one can observe that the method provides an accurate regularized
version of SA since, as previously reported, physical activity does not alter
SA. In contrast, the method is not able to follow the rapid changes on TTR
signal (Figure 4.4, middle panels) and data overfitting can be observed on
glucose signal (Figure 4.4, bottom panels). The inability of the method to
provide an accurate regularization of TTR and glucose signals, and thus their
derivatives, is due to the effect of physical activity that, in this case, has not
been taken into account.
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Figure 4.4: Average data vs. reconvolution (left) and weighted residuals (right)
obtained with the standard stochastic deconvolution method. [6 −3 H]glucose-to-
[1−13C]glucose ratio (top), [6, 6−2H2]glucose-to-endogenous glucose ratio (center-
right) and glucose signal (bottom).
Finally, in Figure 4.5, average postprandial glucose fluxes obtained with the
one- and two-compartment model using derivatives of SA, TTR and gluc-
ose signals calculated with the standard stochastic deconvolution method
are showed. As can be observed, Ra meal obtained with the one- and two-
compartment model are very similar one to each other thanks to the well
clamped SA. In contrast, EGP and Rd are not perfectly superimposable, pos-
sibly due to the rapid changes in both G2H/Gend and glucose signals which
amplify models errors. However, even if the slight superiority of the two-
vs. one-compartment model in the postprandial setting [4], in this experi-
mental conditions, EGP and Rd calculated with the two-compartment model
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Figure 4.5: Average Ra meal (top), EGP (middle) and Rd (bottom) fluxes ob-
tained with the one- (1CM) and two-compartment (2CM) model with derivatives
of SA, TTR and glucose signals obtained with the standard stochastic deconvolu-
tion method.
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exhibit, in some cases, unphysiological behaviours, e.g negative values and
less smoother signals, respect to the one-compartment model. Likely, these
are due to unknown effects of physical activity on the exchange parameters
between the two glucose compartments, fixed to population values, and this
error may be amplified due to TTR and glucose rapid variations.
Improved stochastic deconvolution method
Assuming that a nonstationarity is introduced due to physical activity,
an improved stochastic deconvolution method is adopted. It assumes that the
expectations on the smoothness of the unknown input signal can be modeled
as a multiple integration of a white noise process but, in this case, with time-
varying statistics. This effect is particularly remarkable on both TTR and
glucose signals (Figure 4.4), but not on SA. For this reason, this method is
not applied to SA, but only to TTR and glucose signals.
In Figures 4.6 average data vs. reconvolution (left) and weighted resid-
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Figure 4.6: Average data vs. reconvolution (left) and weighted residuals (right)
obtained with the improved stochastic deconvolution method maximizing the like-
lihood function L of the data for the estimation of the optimal combination of
parameters (α21, α
2
2 and τ). [6, 6 −2 H2]glucose-to-endogenous glucose ratio (top)
and glucose signal (bottom).
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uals (right) of G2H/Gend and glucose signals obtained with the improved
stochastic deconvolution method are showed. One can observe that this
method provides an accurate regularized version of both TTR and glucose
signal. In fact, the reconvoluted TTR (Figure 4.6, top panel) well follows
the rapid changes of TTR signal, while weighted residuals of glucose signal
(Figure 4.6, lower panel) are well distributed. Median and interquartile range
of parameters α21, α
2
2 and τ , estimated maximizing the likelihood function L
of the data, are reported in Table 4.1.
For TTR and glucose signals, on average, α21 and α
2
2 are greater and lower,
α21 α
2
2 τ
TTR
9.5 0.117 160
(1.55− 15) (0.05− 2.5) (147.5− 165)
Glucose
6 0.053 160
(0.28− 8.5) (0.027− 1) (150− 170)
Table 4.1: Median and interquartile range of parameters α21, α
2
2 and τ estimated
applying the improved stochastic deconvolution method on TTR (top) and glucose
(bottom) signals maximizing the likelihood function L of the data for the estimation
of the optimal combination of parameters (α21, α
2
2 and τ).
respectively, than 1 (which would have meant same statistical properties
during meal and exercise phase). This can be due to physical activity which
introduces a nonstationarity from the start of the exercise phase (α21) to ap-
proximately τ = 160 min, while a more stationary phase, the recovery phase
(α22), lasts till the end of the experiment for both signals.
In Figure 4.7, average EGP and Rd fluxes obtained with the one- and two-
compartment model using derivatives calculated with the improved stochastic
deconvolution method are showed. As can be observed, EGP and Rd are
slightly different from those obtained with the standard stochastic decon-
volution method (Figure 4.5), especially during exercise. In fact, EGP rises
faster, thanks to a more accurate estimation of TTR derivatives which better
follows the rapid changes in TTR signal, while Rd is more smoothed, thanks
to a smoother glucose derivatives in this phase.
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Figure 4.7: Average EGP (top) and Rd (bottom) fluxes obtained with the one-
(1CM) and two-compartment (2CM) model with derivatives of TTR and glucose
signals obtained with the improved stochastic deconvolution method maximizing
the likelihood function L of the data for the estimation of the optimal combination
of parameters (α21, α
2
2 and τ).
However, the use of the block matrix Λ (Eq. 4.64) and a criterion for
the choice of the optimal combination of parameters (α21, α
2
2 and τ) which
consider signals as made up of discontinuous components due to sudden vari-
ations of statistics properties of the a priori model, can lead sometimes to
undersmoothing, probably caused by compensation effects between the es-
timated parameters.
For example, in Figure 4.8, the criterion proposed in [90], i.e. maximization
of the likelihood function L of the data for the estimation of the optimal
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Figure 4.8: Data vs. reconvolution (left) and weighted residuals (right) ob-
tained with the improved stochastic deconvolution method maximizing the like-
lihood function L of the data for the estimation of the optimal combination of
parameters (α21, α
2
2 and τ). [6, 6−2 H2]glucose-to-endogenous glucose ratio of sub-
ject 04 (top) and glucose signal of subject 01 (bottom).
combination of parameters (α21, α
2
2 and τ), leads both TTR and glucose sig-
nals to be undersmoothed. This issue can be related to the fact that the
variations on the regularity of the a priori model of TTR and glucose signals
may not always be modeled as a sudden variation, i.e. in some cases this
variation may change more smoothly.
For this reason here the new criterion, based on the statistical properties of
weighted residuals, for the estimation of the optimal combination of para-
meters is used (Eqs. 4.65 and 4.66), in order to maintain the structure of
Eq. 4.64 but avoiding oversmoothing.
By comparing reconvoluted TTR and glucose signals obtained with the two
criteria in Figures 4.8 and 4.9, one can observe the improvements introduced
by the new criterion (Eqs. 4.65 and 4.66) which allows a better fit of the
data, reducing the undersmoothing phenomena. However, as can be observed
by comparing Figures 4.6 and 4.10, this may always be the case. In fact, on
average, results obtained with the two criteria are very similar, meaning that
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Figure 4.9: Data vs. reconvolution (left) and weighted residuals (right) obtained
with the improved stochastic deconvolution method using the new criterion pro-
posed for the estimation of the optimal combination of parameters (α21, α
2
2 and
τ). [6, 6−2 H2]glucose-to-endogenous glucose ratio of subject 04 (top) and glucose
signal of subject 01 (bottom).
the assumption of a rapid variation of stationarity introduced by physical
activity is valid in most cases. However, the use of the new criterion wor-
sens weighted residuals, but this was an expected consequence since the new
criterion allows a more smoothed reconstruction of TTR and glucose sig-
nals, leading to a lower adherence to noisy experimental data. Median and
interquartile range of parameters α21, α
2
2 and τ , estimated with the new cri-
terion proposed are reported in Table 4.2.
As reported in Table 4.2, on average, α21 of TTR signal is greater than 1
while α21 of glucose signal is approximately equal to 1. This means that the
nonstationarity introduced by physical activity is more pronounced in the
TTR signal between the exercise and meal phase. In contrast, both α22 of
TTR and glucose signals are lower than 1 leading to a more regular recovery
phase, as expected. As a remark, looking at the average value of τ reported
in Table 4.1, here the effect of exercise seems to last a bit longer.
In Figure 4.11, average EGP and Rd fluxes obtained with the one- and two-
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Figure 4.10: Average data vs. reconvolution (left) and weighted residuals (right)
obtained with the improved stochastic deconvolution method using the new cri-
terion proposed for the estimation of the optimal combination of parameters (α21,
α22 and τ). [6, 6−2 H2]glucose-to-endogenous glucose ratio (top) and glucose signal
(bottom).
α21 α
2
2 τ
TTR
4 0.167 170
(1.625− 11.75) (0.032− 0.625) (150− 195)
Glucose
1 0.031 187.5
(1− 2) (0.014− 0.087) (180− 195)
Table 4.2: Median and interquartile range of parameters α21, α
2
2 and τ estimated
applying the improved stochastic deconvolution method on TTR (top) and gluc-
ose (bottom) signals using the new criterion proposed for the estimation of the
combination of parameters (α21, α
2
2 and τ).
compartment model using derivatives calculated with the improved stochastic
deconvolution method and the new criterion are showed. As TTR and gluc-
ose reconvoluted signals (Figure 4.7), EGP and Rd are very similar to the
ones obtained with the other improved deconvolution method.
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Figure 4.11: Average EGP (top) and Rd (bottom) fluxes obtained with the one-
(1CM) and two-compartment (2CM) model with derivatives of TTR and glucose
signals obtained with the improved stochastic deconvolution method using the new
criterion proposed for the estimation of the optimal combination of parameters (α21,
α22 and τ).
4.5.3 Postprandial glucose fluxes
Here a brief discussion about postprandial glucose fluxes estimated with
the triple-tracer approach is reported. Ra meal obtained with the one- and
two-compartment were very similar one to each other because plasma concen-
trations of tracer and tracee changed in parallel throughout the study and, for
this reason, the standard deconvolution technique was adequate to allow an
accurate reconstruction of SA and its derivative. In contrast, the reconstruc-
tion of EGP and Rd fluxes has been more complicated since the rapid changes
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in both G2H/Gend and glucose signals probably due to nonstationarity in-
troduced by physical activity. For these two signals, the one-compartment
model and the improved stochastic deconvolution method for derivatives cal-
culation were chosen. The one-compartment model was selected since, in this
particular conditions (moderate-intensity physical activity), estimated gluc-
ose fluxes showed a more physiological behaviour, i.e. smoother signals and
avoiding negative values, with respect to the two-compartment. In addition,
a part from the clear advantages of the improved stochastic deconvolution
method in reconstructing TTR and glucose signals, the adoption of the new
criterion proposed allows a more regular reconstruction of both TTR and
glucose profiles.
As reported in the upper panel of Figure 4.5, Ra meal fell rapidly during
the first 10 min of exercise (t = 120−130 min) but thereafter reached a plat-
eau at rates similar to that observed at t = 10 min for the remaining duration
of the exercise period. Subsequently, Ra meal rapidly declined to near zero by
t = 240 min (i.e., within 35 min) after completion of exercise. The transient
plateau in Ra meal during exercise could be because of an exercise-induced in-
crease in visceral sympathetic nerve activity delaying gastric emptying rates.
Prior reports on the direct effects of exercise on rates of gastric emptying
have been conflicting, with reports demonstrating either delayed [77, 94] or
no effects [15, 42] on gastric emptying rates in healthy adults. It is possible
that the timing of exercise in relation to the meal is an important determin-
ant of Ra meal. Therefore, an earlier start to the exercise after the meal could
have had a greater effect on Ra meal. Furthermore, a humoral factor that
could have contributed to the plateau in Ra meal includes the rise in glucagon
concentrations during exercise (Figure 3.1, left-lower panel), since glucagon
is known to possess decelerating effects on gastric motility [129].
Glucose concentration at any given time point is a function of the rate of
glucose entering and leaving the circulation. This concept is true in both
the postabsorptive and postprandial situations. Because exercise is known
to increase the rate of glucose leaving the circulation (i.e., Rd), rates of
glucose entering the circulation in the postprandial state (i.e., EGP and/or
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Ra meal) must also increase to compensate for the physiological increase in Rd
to prevent hypoglycemia. Because glucose concentrations fell below baseline
fasting levels during exercise in all subjects, the rate of glucose leaving the
circulation (i.e., Rd) must have exceeded the rate of glucose entering the cir-
culation (i.e., combined rates of EGP and Ra meal). It is noteworthy, however,
that these dynamic changes were occurring in the presence of rapidly falling
insulin concentrations during exercise. Although the almost eightfold rise in
rates of EGP from the start to the end of exercise (Figure 4.11, top panel)
could be explained by both falling insulin and rising glucagon concentrations,
the plateau in Rd (Figure 4.11, bottom panel) during exercise (t = 140− 180
min) can be explained by increasing muscle glucose uptake by both insulin-
independent and -dependent mechanisms. The sustained rate of Rd during
exercise, however, was only in part compensated by the eightfold increase in
EGP and a transient plateau in the rate of Ra meal from the gastrointestinal
tract. Furthermore, exercise is also known to increase rates of blood flow to
exercising muscles [2, 92], thereby contributing, at least in part, to enhanced
muscle glucose uptake [53].
In conclusion, in this section, a description of postprandial glucose turnover,
during moderate-intensity physical activity, has been presented. A rapid
eightfold increase in rates of EGP with a plateau in the rates of both Ra meal
and Rd were showed, while glucose concentrations rapidly fell below baseline
fasting levels in all subjects accompanied by a rapid fall in insulin concen-
trations together with greater than twofold rise in glucagon concentrations.
The implemented methods for the estimation of glucose fluxes and their
results have been published in [104].

5
Estimation of Insulin Sensitivity during
Exercise
5.1 Introduction
Excellent, but complex, methods are available for the quantitative as-
sessment of insulin sensitivity (SI), i.e. the ability of insulin to stimulate
glucose disposal (Rd) and inhibit endogenous production (EGP), employing
intravenous administration of insulin and/or glucose, e.g. hyperinsulinemic
euglycemic clamp [37] and intravenous glucose tolerance test (IVGTT) [6].
However, given the difficulty of venous administration and the nonphysiolog-
ical experimental conditions, it would have been highly desirable to obtain
an accurate measure of SI from oral administration. More recently, methods
based on meal and oral glucose tolerance test (MTT and OGTT, respect-
ively), e.g. the oral glucose minimal model [30, 32] and surrogate measures
[55, 85, 112], have been developed. However, none of these methods have
been tested and validated when these perturbations are further challenged
by exercise.
In this Chapter a method is presented to assess the effect and effect size
of physical activity on insulin sensitivity, which employs the glucose fluxes
estimated in Chpater 4. To do that, insulin sensitivity is estimated in absence
and in presence of physical activity. Thanks to glucose fluxes availability, it
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was possible also to tease out the contribution of liver and disposal insulin
sensitivity. Then, a well-established integral formula [21], for the estimation
of net insulin sensitivity, based on plasma glucose and insulin concentration
data, was used to compare and validate the obtained results.
5.2 Insulin sensitivity estimation
In this Section two integral formulas for the estimation of insulin sensit-
ivity during a meal are presented. Both methods rely on the minimal model
of glucose regulation [6], but with some fundamental differences.
The first one is based on reconstructed postprandial glucose fluxes and the
model is coupled with a simple mathematical description of the effect of gluc-
ose and insulin on EGP and Rd, while the other one is based on glucose and
insulin data and the model is coupled with a simple mathematical description
of glucose absorption from the gastrointestinal tract.
5.2.1 Insulin sensitivity from postprandial glucose fluxes
In this Section a method for the estimation of net (STOTI ), liver (S
L
I ) and
disposal (SDI ) insulin sensitivity, based on reconstructed postprandial glucose
fluxes is proposed. The method is based on the minimal model of glucose
regulation [6] by adopting a simple mathematical description of the effect of
glucose and insulin on EGP and Rd (Fig. 5.1). The model describing EGP
is given by
EGP (t) = EGPb −GEL · (G(t)−Gb)− SLI ·X ′(t)G(t)
EGP (0) = EGPb (5.1)
5.2 Insulin sensitivity estimation 63
Glucose 
G 
Remote 
Insulin 
I’ 
EGP 
Periphery 
SI
L 
Plasma 
Insulin 
(I-Ib) 
Liver 
Ra 
SI
D 
GEL GE
D 
Rd 
Figure 5.1: Minimal model of glucose regulation [6] adopting a simple description
of the effect of glucose and insulin on EGP and Rd.
while the model describing Rd is given by
Rd(t) = Rdb +GE
D · (G(t)−Gb) + SDI ·X ′(t)G(t)
Rd(0) = Rdb (5.2)
where EGPb and Rdb are basal EGP and Rd, GEL and GED are the liver
and disposal glucose effectiveness, SLI and S
D
I are liver and disposal insulin
sensitivity, respectively. X' is the delayed insulin action (deviation from
basal) defined as
X˙ ′(t) = −p2 ·X ′(t) + p2 · [I(t)− Ib] X(0) = 0 (5.3)
where p2 is the speed of rise and decay of insulin action.
Moreover, combining Eqs. 5.1 and 5.2, a model describing the net effect of
insulin and glucose on both disposal and production is obtained
Rd(t) = EGP (t) +GE
TOT · [G(t)−Gb] + STOTI ·X ′(t)G(t)
Rd(0) = EGPb (5.4)
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where GETOT = GEL + GED and STOTI = S
L
I + S
D
I . By integrating Eq. 5.3
describing insulin action and assuming that at the end of the perturbation the
insulin system returns at the pretest steady state, the following expression is
obtained ∫ ∞
0
X(t)dt =
∫ ∞
0
[I(t)− Ib]dt (5.5)
whereas integrating Eqs. 5.1, 5.2 and 5.4 we obtain, rescpectively
SLI ·
∫ ∞
0
X(t)dt =
∫ ∞
0
−∆EGP (t)−GEL ·∆G(t)
G(t)
dt (5.6a)
SDI ·
∫ ∞
0
X(t)dt =
∫ ∞
0
∆Rd(t)−GED ·∆G(t)
G(t)
dt (5.6b)
STOTI ·
∫ ∞
0
X(t)dt =
∫ ∞
0
Rd(t)− EGP (t)−GETOT ·∆G(t)
G(t)
dt (5.6c)
Thus, substituting Eq. 5.5 into Eqs. 5.6, the following expression for liver,
disposal and total insulin sensitivity are obtained
SLI,TT =
∫∞
0
−∆EGP (t)−GEL·∆G(t)
G(t)
dt∫∞
0
[I(t)− Ib]dt
(5.7a)
SDI,TT =
∫∞
0
∆Rd(t)−GED·∆G(t)
G(t)
dt∫∞
0
[I(t)− Ib]dt
(5.7b)
STOTI,TT = S
L
I,TT + S
D
I,TT =
∫∞
0
Rd(t)−EGP (t)−GETOT ·∆G(t)
G(t)
dt∫∞
0
[I(t)− Ib]dt
(5.7c)
where the subscript TT indicates that these indices are derived from the
fluxes measured with the triple tracer approach.
As can be observed in Eqs. 5.7, calculation of liver, disposal and net insulin
sensitivity from postprandial glucose fluxes, requires values for GEL, GED
and GETOT which are generally fixed to population values [21, 33] since in-
dividual estimates are not available.
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5.2.2 Insulin sensitivity from plasma glucose and insulin
data
In this Section a method for the estimation of SI, in healthy subjects,
based on plasma glucose and insulin data [21] is presented. The method is
based on an integral formula obtained coupling the classical minimal model
of glucose kinetics [6] with a simple mathematical description of glucose ab-
sorption from the gastrointestinal tract.
During an oral test (e.g. a meal) the food is ingested and nutrients, includ-
ing glucose, encounter the systemic circulation only after absorption from
the gastrointestinal tract and passage through the liver. The general formu-
OGTT/MTT 
k3 
Glucose 
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Remote 
Insulin 
I’ 
k5 
Periphery 
k1 
k4 k6 
k2 
Plasma 
Insulin 
(I-Ib) 
Liver 
Gastrointestinal Tract 
SI 
Figure 5.2: Classic representation of the minimal model [6] where the ki are
linked to pi of Eq. 5.8 as follows: p1 = k1 + k5, p2 = k3 and p3 = k2 · (k4 + k6). I ′
is remote insulin related to X as X = (k4 +k6) · I ′(t). Ra is the rate of appearance
of glucose in plasma after oral ingestion.
lation of the oral minimal model [30], making explicit the rate of appearance
of exogenous glucose (Fig. 5.2), yieldsG˙(t) = −[p1 +X(t)] ·G(t) + p1 ·Gb +
Ra(t)
V
G(0) = Gb
X˙(t) = −p2 ·X(t) + p3 · [I(t)− Ib] X(0) = 0
(5.8)
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where G is glucose concentration, X is insulin action, I is insulin plasma con-
centration, Ra is the generic expression for the rate of appearance of glucose
in plasma, V is the volume distribution, suffix b denotes basal (pretest)
values, p1 is the fractional (i.e. per unit distribution volume) glucose effect-
iveness (GE) measuring glucose ability per se to promote glucose disposal
and inhibit glucose production, p2 is the speed of rise and decay of insulin
action and p3 is a scale factor governing the size of insulin action.
In [21], Ra is represented as an anticipated version of glucose excursion above
basal
∆G˙(t) = −a ·∆G(t) + b ·Ra(t) (5.9)
where a is a parameter governing the delay and smoothness of ∆G (glucose
excursion above basal) with respect to Ra, and b is s scale factor. Substituting
the expression of Eq. 5.9 into Eq. 5.8 one obtainsG˙(t) = −[p1 +X(t)] ·G(t) + p1 ·Gb +
a·∆G(t)+·∆G˙(t)
bV
G(0) = Gb
X˙(t) = −p2 ·X(t) + p3 · [I(t)− Ib] X(0) = 0
(5.10)
By integrating the the second differential equation of Eq. 5.10 and assuming
that at the end of the perturbation the insulin system returns at the pretest
steady state, the following expression for SI is obtained
SI =
p3
p2
· V =
∫∞
0
X(t)dt∫∞
0
[I(t)− Ib]dt
V (5.11)
By integrating the first differential equation of Eq. 5.10 we obtain∫ ∞
0
X(t)dt =
(
a
b · V −p1
)∫ ∞
0
∆G(t)
G(t)
dt+
(
1
b · V −1
)∫ ∞
0
∆G˙(t)
G(t)
dt (5.12)
Assuming that at the end of the perturbation the glucose system returns at
the pretest steady state, which is a valid assumption especially in healthy
subjects, we obtain that the second integral in the right member is zero.
Moreover, assuming that the ratio a/b is proportional to the amount of gluc-
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ose absorbed during the test one obtains
a
b
=
∫∞
0
Ra(t)dt∫∞
0
∆G(t)dt
=
(f ·D)/BW∫∞
0
∆G(t)dt
(5.13)
where the integral of Ra is expressed as a fraction f of the amount of glucose
D per body weight (BW) that has reached the systemic circulation and p1 ·V
is the glucose effectiveness (GE).
Thus, substituting Eqs. 5.12 and 5.13 into Eq. 5.11, the following expression
for insulin sensitivity is obtained
SI =
(f ·D)/BW ·
∫∞
0
∆G(t)/G(t)dt∫∞
0 ∆G(t)dt
−GE · ∫∞
0
∆G(t)
G(t)
dt∫∞
0
[I(t)− Ib]dt
(5.14)
However, particularly when a session physical activity is performed, the case
in which glucose exhibits excursions below the pretest basal level has to be
considered. Denoting τk with k = 1, . . . , n as the time instants when glucose
concentration crosses the baseline level Gb, evaluated by linearly interpolat-
ing the glucose samples immediately precede and follow the subject-specific
threshold, the description of Ra throughout the experiment has to be accord-
ingly modifying in order to cope with its nonphysiological negative values.
Thus Ra, for each τk−1 < t < τk, can be defined as
Ra(t) =

[a·G(t)+∆G˙(t)]
b
if G(t) ≥ Gb
− [a·G(t)+∆G˙(t)]
b
if G(t) < Gb
(5.15)
Thus, using the same rationale outlined above with Ra described as Eq. 5.15,
one has the following expression for SI
SI =
(f ·D)/BW ·
∫∞
0 |∆G(t)/G(t)|dt∫∞
0 |∆G(t)|dt
−GE · ∫∞
0
∆G(t)
G(t)
dt∫∞
0
[I(t)− Ib]dt
(5.16)
As can be observed in Eq. 5.16, calculation of SI requires values both for GE
and f which generally are fixed to population values [21, 30] since individual
estimates are not available.
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5.3 Quantification of exercise effect on insulin
sensitivity
Exercise is known to improve insulin action in the postexercise period
[51, 52], but quantification of this effect, especially in the postprandial state
has been difficult to estimate.
The approach proposed here for the quantification of the effect size of physical
activity on postprandial insulin sensitivity relies on calculating SI both in
absence and in presence of physical activity. Since at t = 0 min the meal
was ingested, between t = 120 min and t = 195 min the exercise session was
performed and at t = 360 min the experiment ended, two indices of insulin
sensitivity can be calculated: one in absence of physical activity (rest), i.e.
between t = 0 − 120 min, and one in presence of physical activity (overall),
i.e. between t = 0− 360 min.
The same rationale is thus extended to insulin sensitivity indices calculated
from postprandial glucose fluxes as well as from glucose and insulin data as
outlined below.
Insulin sensitivity from postprandial glucose fluxes
Starting from Eqs. 5.7 one can calculate liver, disposal and net insulin
sensitivity both in absence and in presence of physical activity:
• SrestI,TT: calculated for t = 0 − 120 min, i.e. integrating Eqs. 5.7 from
the beginning of the meal to the beginning of the exercise session, thus
5.3 Quantification of exercise effect on insulin sensitivity 69
calculating SI,TT in absence of physical activity:
Srest,LI,TT =
∫ 120
0
−∆EGP (t)−GEL·∆G(t)
G(t)
dt∫ 120
0
[I(t)− Ib]dt
(5.17a)
Srest,DI,TT =
∫ 120
0
∆Rd(t)−GED·∆G(t)
G(t)
dt∫ 120
0
[I(t)− Ib]dt
(5.17b)
Srest,TOTI,TT =
∫ 120
0
Rd(t)−EGP (t)−GETOT ·∆G(t)
G(t)
dt∫ 120
0
[I(t)− Ib]dt
(5.17c)
• SoverallI,TT : calculated for t = 0 − 360 min, i.e. integrating Eqs. 5.7 from
the beginning of the meal to the end of experiment, thus calculating
SI,TT in presence of physical activity:
Soverall,LI,TT =
∫ 360
0
−∆EGP (t)−GEL·∆G(t)
G(t)
dt∫ 360
0
[I(t)− Ib]dt
(5.18a)
Soverall,DI,TT =
∫ 360
0
∆Rd(t)−GED·∆G(t)
G(t)
dt∫ 360
0
[I(t)− Ib]dt
(5.18b)
Soverall,TOTI,TT =
∫ 360
0
Rd(t)−EGP (t)−GETOT ·∆G(t)
G(t)
dt∫ 360
0
[I(t)− Ib]dt
(5.18c)
Insulin sensitivity from plasma glucose and insulin data
Starting from Eq. 5.16 one can calculate net insulin sensitivity both in
absence and in presence of physical activity:
• SrestI : calculated for t = 0 − 120 min, i.e. from the beginning of the
meal to the beginning of the exercise session, i.e. in absence of physical
activity:
SrestI =
(frest·D)/BW ·
∫ 120
0 |∆G(t)/G(t)|dt∫ 120
0 |∆G(t)|dt
−GE · ∫ 120
0
∆G(t)
G(t)
dt∫ 120
0
[I(t)− Ib]dt
(5.19)
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where f rest represents the fraction of the meal absorbed during the
interval t = 0− 120 min (its calculation is described below).
• SoverallI : calculated for t = 0 − 360 min, i.e. from the beginning of the
meal to the end of experiment, i.e. in presence of physical activity:
SoverallI =
(foverall·D)/BW ·
∫ 360
0 |∆G(t)/G(t)|dt∫ 360
0 |∆G(t)|dt
−GE · ∫ 360
0
∆G(t)
G(t)
dt∫ 360
0
[I(t)− Ib]dt
(5.20)
where f overall represents the fraction of the meal absorbed during the
interval t = 0− 360 min (its calculation is described below). However,
it is important to remark that this value includes either the rest and
the physical activity effect on SI .
It is worth noting that at t = 120 min the meal has not been fully absorbed
and this has to be taken into account when calculating the amount of Ra meal
which appears in the circulation. In this study, thanks to the triple-tracer
technique, we actually estimated the Ra meal profile. This allowed the calcu-
lation of the time-varying fraction of the ingested dose f as the ratio between
the area under the Ra meal curve and the amount of ingested glucose D. For
our purpose, we calculated two values for f
f rest =
∫ 120
0
Ra meal
D/BW
f overall =
∫ 360
0
Ra meal
D/BW
(5.21)
representing the fraction of the glucose dose which appears into systemic
circulation from the beginning of the meal to the beginning of exercise (Eq.
5.21, left) and for the whole experiment (Eq. 5.21, right), respectively.
5.4 Results
Data are presented as mean ± SE, if not differently indicated. Student's
paired two-sample t-test (significance level set to 5%) was used for com-
parison. Pearson's correlation was used to evaluate univariate correlation.
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Insulin sensitivity indices were averaged on a total of 11 subjects, since an
error on the measurement of meal enrichment was reported in one subject.
Values obtained at t = 0 min were considered as basal.
Insulin sensitivity from postprandial glucose fluxes
In this model, for the calculation of liver, disposal and net insulin sensit-
ivity from postprandial glucose fluxes, one has to fix GEL and GED to pop-
ulation values. From previous studies [33], we know that the ratio between
GEL and GED to GETOT can be approximated to 1/3 and 2/3, respectively,
of total glucose effectiveness (GETOT), which is generally fixed to population
value (0.02 dL/kg/min) according to [21].
In Figure 5.3 average values of rest vs overall liver (SLI,TT), disposal (S
D
I,TT)
and net (STOTI,TT ) insulin sensitivity indices (top) and individual values of rest vs
overall net (Srest,TOTI,TT vs S
overall,TOT
I,TT ) insulin sensitivity index (bottom) estim-
ated from postprandial glucose fluxes are reported. No significant difference
has been found between Srest,LI,TT and S
overall,L
I,TT (2.56± 0.54 vs 3.36± 1.26 10−4
dL/kg/min per µU/mL, p>0.05), while Srest,DI,TT and S
rest,TOT
I,TT are significantly
lower than Soverall,DI,TT (13.06±2.79 vs 22.16±4.43 10−4 dL/kg/min per µU/mL,
p<0.005) and Soverall,TOTI,TT (15.62 ± 3.27 vs 25.52 ± 5.02 10−4 dL/kg/min per
µU/mL, p<0.005), respectively. Moreover, if one observes the individual
estimates of rest vs overall net insulin sensitivity, each Soverall,TOTI,TT value is
significantly higher than the corresponding Srest,TOTI,TT .
These results show that overall insulin sensitivity, i.e. the average of
insulin sensitivity during the entire experiment, is 76±12% higher respect to
rest insulin sensitivity and that this effect is due to an enhancement in glucose
disposal rather than a further suppression of EGP. In fact, the absence of
systematic variation in SLI,TT, before and after the exercise session, means
that insulin seems do not exert a significant effect on EGP during physical
activity. This effect may be due to either, from a modeling point of view,
to having fixed to population values the ratio between GEL and GED, and,
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Figure 5.3: Rest vs overall of average values of liver, disposal and net insulin
sensitivity indices (top) and of individual values of net insulin sensitivity index
(bottom) estimated from postprandial glucose fluxes with the method proposed in
Section 5.2.1.
from a physiological point of view, that the inhibitory effect of insulin on
EGP is relatively minor compared to the stimulatory effect of glucagon on
EGP. On the contrary, a significant effect seems to be exerted by insulin
on glucose disposal: even though insulin and glucose rapidly fall, sustained
rate of Rd are showed during exercise, possibly due to an increased glucose
uptake by insulin-dependent mechanisms. It is known, however, that glucose
disposal during and after exercise is also determined by insulin-independent
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effects [48, 49, 114, 128], but this method cannot specifically tease out the
insulin-independent effects on muscle glucose uptake induced by exercise.
Insulin sensitivity from glucose and insulin data
In this model, for the calculation of net insulin sensitivity from glucose
and insulin concentration data, one has to fix GE and f to population values.
GE is generally fixed to 0.02 dL/kg/min, according to [21] while f can vary
between 0.8 to 0.9, as reported in [21, 29, 30, 32]. In this study, since we
actually estimated the Ra meal profile, we can calculate the value of f . Here
high values of f overall have been calculated on average equal to 1.09 ± 0.22.
We thus fixed all f overall calculated equal to 1. The same rationale is thus
extended also to the calculation of f rest, where each value has been normal-
ized respect to its f overall.
In Figure 5.4 average (top) and individual values of rest vs overall net (SrestI
vs SoverallI ) insulin sensitivity index (bottom) estimated from glucose and in-
sulin concentration data are reported. As can be observed SrestI is significantly
lower than SoverallI (12.83± 2.22 vs 21.92± 3.99 10−4 dL/kg/min per µU/mL,
p<0.005). Moreover, if one observes the individual estimates of rest vs overall
net insulin sensitivity, each SoverallI value is higher than the corresponding S
rest
I .
These results show that, in agreement with prior results on net insulin
sensitivity index calculated from postprandial glucose fluxes (STOTI,TT ), S
overall
I is
74±8% higher than SrestI . At variance with the method proposed above, here
the method does not allow to segregate the effect of insulin on glucose pro-
duction and disposal before, during and after exercise due to the impossibility
to tease out the contribution of the two components only using glucose and
insulin concentration data. However, it allows to quantify the effects of phys-
ical activity on insulin sensitivity just using glucose and insulin concentration
data which needed a much simpler protocol respect to the triple-tracer one.
As a remark, since GE is fixed to population values, also this method does
not allow to tease out the relative contribution of insulin-independent glucose
uptake induced by exercise.
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Figure 5.4: Rest vs overall of average (top) and individual (bottom) values of
net insulin sensitivity index estimated from glucose and insulin concentration data
with the method proposed in Section 5.2.2.
The implemented methods for the quantification of the effect size of exer-
cise on insulin sensitivity calculated from glucose and insulin data and their
results have been published in [104].
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Comparison
Here the aim is to compare and validate the values of net insulin sens-
itivity calculated with the formula proposed in Section 5.2.1 with the well-
established integral formula proposed in [21]. As a remark, for the calculation
of SI with the method proposed in Section 5.2.2, we have normalized the val-
ues of f overall to 1. Thus, in order to do a fair comparison, for the calculation
of SI,TT with the method proposed in Section 5.2.1, it is necessary to rescale
the Ra meal profile of each subject in relation to its f overall. For what concerns
GE, in both model, it is fixed to population value (0.02 dL/kg/min) accord-
ing to [21].
In Figure 5.5 comparison between average values (top) of rest vs overall
(SrestI vs S
rest
I,TT and S
overall
I vs S
overall
I,TT , respectively) and correlation between
rest and overall (bottom) of the two indices calculated (SI vs SI,TT) are re-
ported. Average values of net insulin sensitivity at rest (12.83 ± 2.22 vs
13.97± 2.54 10−4 dL/kg/min per µU/mL, p=0.06) and overall (21.92± 3.99
vs 23.12 ± 3.93 10−4 dL/kg/min per µU/mL, p=0.05) net insulin sensitiv-
ity indices estimated with the two methods are very similar, even if SI,TT is
significant higher than SI (p=0.0044). However, on average, both rest SI,TT
and SI values are significantly lower respect to their corresponding overall es-
timates (p<0.005). Moreover, we found a very strong correlation (r=0.989,
p0.005) between the two indices which allows us to validate the results
obtained with the proposed formula.
These results confirmed that for both SI,TT and SI indices, during a ses-
sion of moderate-intensity exercise, insulin sensitivity is 77±12% and 74±8%
higher, respectively. However, it is important to remark that, the overall in-
sulin sensitivity represents the average insulin sensitivity during the entire
duration of the experiment, i.e. it accounts for insulin sensitivity before, dur-
ing and after the session of physical activity. Moreover, with the proposed
method, we are able only to quantify an insulin-dependent effects of exer-
cise on glucose uptake while, unfortunately, it is not possible to tease out
the relative contribution of the well-established insulin-independent mech-
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Figure 5.5: Comparison between average rest vs overall (top) of SI and SI,TT and
correlation (bottom) between all SI and SI,TT values (rest and overall) estimated
with the methods proposed in 5.2.1 and 5.2.2, respectively.
anisms induced by exercise, e.g. increase in muscle blood flow [2, 92], ca-
pillary recruitment and exercise-induced translocation of GLUT-4 protein
[48, 49, 114, 128].
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5.5 Use of results
This Section has been realized in collaboration with our clinical partners,
exploiting information on the effect of moderate-exercise physical activity in
healthy subjects, to suggest an optimization strategy of insulin therapy in
T1DM patients during exercise.
Here, an in silico study aimed to assess the effect of moderate-intensity phys-
ical activity in T1DM subjects under continuous subcutaneous insulin infu-
sion (CSII) therapy regimen and to propose a strategy for the optimization
of subcutaneous insulin infusion rate during exercise. The results presented
in Section 5.4, i.e. the almost doubled increase in insulin sensitivity after a
session of moderate-intensity physical activity in healthy subjects, have been
incorporated in the UVA/Padova T1DM simulator [35, 70] to simulate a ses-
sion of moderate-intensity physical activity. In order to evaluate the effect
of physical activity with different insulin therapy regimens, two in silico ex-
periments, including a session of physical activity, have been performed: one
maintaining the insulin infusion rate at the same level used at rest and one
with different degrees of reductions and durations of basal insulin infusion
rates. Results showed that physical activity markedly affects glucose control
and an insulin therapy optimization strategy would be useful to improve dia-
betes management during exercise.
If the reader is not interested in this particular application, he can skip
this paragraph without compromising the understanding of the following
chapters.
5.5.1 Introduction
Due to the inability of the pancreas to produce insulin, patients with
T1DM use exogenously administered insulin to maintain blood glucose (BG)
concentration in the near-normal range (70-180 mg/dL). Severe hypogly-
cemia can be very dangerous, possibly leading to coma and ultimately to
death, while sustained hyperglycemia may cause long-term microvascular and
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macrovascular complications. However, BG control is extremely challenging
due to the delay between insulin administration and action, physiological
perturbations (i.e. meals and physical activity) and intrasubject variability.
Thanks to the availability of continuous glucose monitoring (CGM) systems
and continuous subcutaneous insulin infusion (CSII) pumps, researchers have
focused on the development of a wearable artificial pancreas (AP), a system
able to modulate subcutaneous insulin infusion rates automatically based
on CGM readings, thus helping in optimally controlling BG [26]. Artificial
pancreas prototypes have been tested successfully in inpatient trials, demon-
strating reduced occurrence of hypoglycemia with respect to standard ther-
apy, increased time spent in the target range, and reduction of mean glucose
[11, 62, 66, 79, 110, 130]. Some of these trials [11, 79] included a session of
physical activity in order to test the ability of the control algorithm to deal
with the rapid changes in insulin sensitivity due to exercise and prevent the
risk of immediate and delayed hypoglycemia associated with daily activity.
In standard therapy, subjects usually, but not always, reduce their basal in-
sulin infusion by a given percentage, starting up to 2 h before exercise session,
but each patient follows his/her own routine and physician suggestions.
It remains a question if one needs to inform the control algorithm regarding
impending physical activity and, if this is the case, the degree and duration
of changes to insulin infusion rates in relation to physical activity. In partic-
ular, model predictive control algorithms (e.g., [89, 107]) may benefit greatly
from the availability of this information because they can use it to predict
future glucose level and adjust insulin infusion rates accordingly. The issue is
particularly important because maintaining unchanged basal infusion rates
in the presence of physical activity often leads to hypoglycemia.
5.5.2 Incorporating the effect of physical activity into
the UVA/Padova T1DM simulator
In this Section the inclusion of the effect of physical activity in the
UVA/Padova T1DM simulator, by using the results shown in Section 5.4,
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is presented.
The UVA/Padova T1DM simulator
The UVA/Padova T1DM simulator [35, 70] is a tool accepted by the
Food and Drug Administration as a substitute for preclinical trials of certain
insulin treatments, including closed-loop control algorithms (Figure 5.6). It
describes the glucose dynamics during a meal by putting in relation plasma
glucose, insulin, and glucagon concentrations with glucose fluxes (endogen-
ous glucose production, glucose rate of appearance, glucose utilization, renal
excretion), insulin fluxes (rate of insulin appearance from subcutaneous tis-
sue, insulin degradation), and glucagon fluxes (glucagon secretion, glucagon
degradation). However, the effect of physical activity was not yet been in-
cluded in the simulator.
The primary effect of physical activity is to enhance glucose utilization by
the tissues [17] (Figure 5.6, red arrow). The model of glucose utilization
currently implemented in the simulator assumes that glucose kinetics are de-
scribed by two compartments, that insulin-independent glucose utilization by
the brain and the erythrocytes takes place in the first compartment (plasma
and rapidly equilibrating tissues) and is constant, while insulin-dependent
glucose utilization (Uid) takes place in the remote compartment (slowly equi-
librating tissues) and depends nonlinearly from glucose in the tissues: in-
sulin system returns at the pretest steady state, the following expression is
obtained
Uid(t) =
[Vm0 + VmX ·X(t) · (1 + r1 · risk)] ·Gt(t)
Km0 +Gt(t)
(5.22)
where Gt(t) is glucose mass in the peripheral compartment; Vm0, VmX , Km0,
and p2U are model parameters; and, in particular, VmX represents insulin
sensitivity, i.e., the ability of insulin to stimulate glucose utilization. Insulin
action X(t) on glucose utilization is described by
X˙(t) = −p2U ·X(t) + p2U · [I(t)− Ib] (5.23)
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Figure 5.6: The new version of T1DM simulator [35] with the effect of physical
activity evidenced. S.C. stays for subcutaneous.
where p2U is the rate constant of insulin action on the peripheral glucose
utilization and I(t) is plasma insulin concentration (suffix b denotes basal
state). Moreover, to describe insulin action in the hypoglycemic range, X(t)
is modulated by the glucose risk function [69]:
risk =

0 if G ≥ Gb
10 · [f(G)]2 if Gth ≤ G < Gb
10 · [f(Gth)]2 if G < Gth
(5.24)
with Gb the basal glucose, Gth the hypoglycemic threshold (set at 60 mg/dL),
and
f(G) = log
( G
Gb
)r2
(5.25)
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with r1 and r2 model parameters.
Please refer to [35] for more details on the complete set of model equations.
Modeling the effect of physical activity
Results presented in Section 5.4 showed that insulin sensitivity in healthy
subjects, after a moderate-intensity session of physical activity (SoverallI ), al-
most doubled respect to the rest value (SrestI ). However, S
overall
I is basically
the average of SI in the entire duration of the experiment. To single out
the actual value of SI during exercise (SexI ), one can assume that SI is equal
to SrestI for t ≤ 120, equal to SexI for 120 < t ≤ 195 and decreases linearly
from SexI to S
rest
I in 195 < t ≤ 360 (Figure 5.7, top panel, pink line). With
this assumption, the average SI during the whole experiment (SoverallI ) can be
calculated by integrating the SI profile of Figure 5.7 from tmeal and tend and
dividing it by the length of the integration interval (tend − tmeal):
SoverallI =
SrestI · (tex,start − tmeal) + SexI · (tex,end − tex,start) + (S
ex
I +S
rest
I )·(tend−tex,end)
2
(tend − tmeal)
(5.26)
thus
SrestI · (tex,start − tmeal) + SexI · (tex,end − tex,start)+
(SexI + S
rest
I ) · (tend − tex,end)
2
= SoverallI · (tend − tmeal) (5.27)
Moreover, assuming that SexI is α·SrestI and, as reported in Chapter 5, approx-
imating SoverallI as twice S
rest
I , we can explicitly calculate α from
SrestI · (tex,start − tmeal) + α · SrestI · (tex,end − tex,start)+
(1 + α) · SrestI ) · (tend − tex,end)
2
= 2 · SrestI · (tend − tmeal) (5.28)
82 Estimation of Insulin Sensitivity during Exercise
where tmeal and tend are time of the meal and time of the end of experiment,
while tex,start and tex,end are time of the start and end of the exercise session,
respectively, obtaining α = 3.29. This approximation, i.e. the nonphysiolog-
ical step increase in insulin sensitivity, is acceptable as far as the duration
of the experiment is much longer than the time constant of exercise action
on glucose utilization. However, simulations can be redefined if a reliable
physiological model is formulated.
Finally, this effect of exercise on glucose dynamics was incorporated into the
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Figure 5.7: Simulation scenario mimicking the experimental protocol reported
in Chapter 3 (top) with the exercise session (pink line). Standard premeal insulin
bolus given at mealtime and basal insulin infusion rate adjustments, with respect
to the patient's profile, during (red arrow) and/or before (blue and green arrows)
the exercise session (bottom). CHO stays for carbohydrate.
UVA/Padova T1DM simulator by modifying accordingly the parameter VmX ,
while all other parameters are maintained fixed to standard UVA/Padova
T1DM population parameters. However, as previously discussed, it is well-
known that physical activity also stimulates non-insulin mediated glucose
transport, but with the method proposed in Chapter 5 the contribution of
this insulin-independent effect of physical activity has not yet been quantitat-
ively assessed, and thus it is not possible at this time to simulate the relative
contributions of insulin-dependent and insulin-independent effects on glucose
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utilization.
5.5.3 In silico experiments
The simulation scenario, mimicking the experimental protocol described
in Chapter 3, consists of a meal (containing 75g of carbohydrates) admin-
istered 3 h after the start of the experiment to 100 in silico adults with T1DM.
The exercise session was simulated to start 2 h after the meal and to last
75 min (Figure 5.7, top panel). The simulation of the exercise session was
obtained by modifying parameter VmX as shown in Figure 5.7 (top panel,
pink line). The virtual subjects received a standard premeal insulin bolus
based on each individual's insulin-to-carbohydrate ratio, while basal insulin
infusion rate was first maintained fixed to patient basal profile (Experiment
1) and then decreased in various degrees and durations in relation to usual
basal insulin infusion rates (Experiment 2).
The optimization strategy aims to explore, in a simulation context, the best
combination of basal insulin infusion rate before and during physical activity
that would prevent hypoglycemia during and after exercise.
Experiment 1
The virtual subjects received their own basal insulin profile, a subject-
specific constant insulin infusion rate able to maintain glucose at steady state
in the absence of external disturbances such as meals and physical activity.
This provided the worst-case scenario to which to compare the simulation
results of Experiment 2.
Experiment 2
The virtual subjects received their own basal insulin profile lowered by
step reductions of 10% during and/or before the exercise session to prevent
hypoglycemia (Figure 5.7, bottom panel), while outside these ranges, they
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received constant rates of basal insulin infusion. In particular, before the
exercise session, step reductions of basal insulin rates ranging from 10% to
60%, with a 10% step, starting 90, 60, and 30 min before the beginning of the
exercise (Figure 5.7, bottom panel, blue and green arrows)were simulated.
During the exercise, reductions ranging from 10% to 60% with a 10% step
have been tested, lasting for the entire exercise duration (Figure 5.7, bottom
panel, red arrow). Outside these time intervals, basal insulin infusion rate was
maintained constant and equal to the patient's basal insulin profile (Figure
5.7, bottom panel, black line).
5.5.4 Results
Results are presented as mean ± SD. Safety (reduction of hypoglycemia)
and efficacy (attenuation of hyperglycemia) of different simulated adjust-
ments to basal insulin infusion rates have been assessed by using the control-
variability grid analysis (CVGA) [81] and by computing the time spent in the
target range of 90-140 mg/dL. For this calculation, simulated glucose profiles
from the start of exercise session to 7 h later, i.e., 3 h after that VmX has
returned to its rest value (Figure 5.7, top panel) were used.
Experiment 1
Simulated plasma glucose concentrations in the 100 T1DM virtual sub-
jects are shown in Figure 5.8 (top-left panel). As expected, most of the sub-
jects experienced hypoglycemia (defined as glucose concentration below 70
mg/dL), with several of them having severe hypoglycemic episodes (defined
as glucose concentration below 50 mg/dL). This is confirmed by the CVGA
(Figure 5.8, bottom-left panel), which shows 15% of the subjects in the lower
C zone, 73% in the lower D zone, no subject in the A zone, and only 12% of
the subjects in the B zone. The average time in target was 28.8± 16.1%.
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Figure 5.8: Simulated plasma glucose concentrations (top panel) and CVGA
(bottom panel) in the 100 T1DM virtual subjects: no basal insulin infusion rate ad-
justment (left panel), optimal mobination of subject-specific adjustments (middle
panel) and optimal combination of population (on average) adjustments (right
panel). Shaded box represents the exercise period.
Experiment 2
The distribution of the optimal combination of basal reductions in the
100 in silico subjects are shown in Figure 5.9. Most of the subjects needed
to reduce their basal insulin of 60% (middle panel) from 90 min before the
start of exercise (Figure 5.9, left panel) and maintain this reduction until the
end of the physical activity (Figure 5.9, right panel). However, there is large
intersubject variability, and the optimal reduction strategy is different from
the one described earlier in a significant proportion of subjects. Therefore,
ideally, one should apply a personalized strategy to each subject. In this case,
in fact, simulations show that the average time in target increases to 90.2±
11.4% and that 96% of the subjects does not experience hypoglycemia (Figure
5.8, top-middle panel) while the remaining 4% only shows mild hypoglycemia
episodes (plasma glucose between 50 and 70 mg/dL). This is also confirmed
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by the CVGA (Figure 5.8, bottom-middle panel), which shows 14% of the
subjects in zone A, 82% in zone B, and only 4% in lower zone D.
Unfortunately, a patient-specific optimal basal reduction strategy is not
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Figure 5.9: Distribution of the opt mal subject-specific combination of basal
reductions in the 100 T1DM virtual subjects: time before the start of physical
activity (left), reduction before physical activity (middle) and reduction during
physical activity (right). PA stays for physical activity.
always available. The simulation results can provide some guidelines in case
this patient-specific information is missing. The basal reduction pattern that
maximizes efficacy and safety in all the 100 in silico subjects, using as a metric
the time spent in the target range of 90-140 mg/dL, was selected. In this
case, a 30% reduction of basal insulin rates during physical activity, preceded
by 50% reduction starting 90 min before the start of physical activity, is the
combination that most effectively guarantees safety and efficacy in most of
the 100 in silico population. As a matter of fact, if this adjustment is applied
to all virtual subjects, average time in target is 72.7 ± 23.5%. The glucose-
simulated profiles are shown in Figure 5.8 (top-right panel), with 84% of the
subjects avoiding hypoglycemia. This was confirmed by the CVGA (Figure
5.8, bottom-right panel): 10% of the subjects lie in the A zone, 74% in the
B zone, 14% in the lower D zone, and 2% in the lower C zone.
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5.5.5 Conclusions
In standard open-loop therapy, subjects usually, but not always, reduce
their basal insulin infusion rates in order to prevent the risk of hypoglycemia
due to the rapid change in insulin sensitivity caused by exercise. In closed-
loop therapy, the need to inform control algorithms regarding impending
physical activity, in order to appropriately reduce insulin infusion rates and
prevent hypoglycemia both during and after exercise, remains debatable.
Here, the results obtained in Section 5.4 on the quantification of the effect
size of physical activity on insulin sensitivity have been incorporated into
the UVA/Padova T1DM simulator. In order to evaluate the effect exercise
on insulin therapy, two in silico experiments, including an exercise session,
have been simulated: one maintaining subject-specific basal insulin infusion
profile and another with varying degrees of reductions and durations of basal
insulin infusion rates. As expected, physical activity markedly affects gluc-
ose control and most of the virtual subjects (88%) experienced hypoglycemia
when no announcement of upcoming physical activity was provided. On
the other hand, if the information on modifications to basal insulin infusion
rates during physical activity is provided to the algorithm, then the safest
and most effective generic reduction of basal insulin rates (16% of hypogly-
cemic events) is a 30% reduction during physical activity, preceded by 50%
reduction starting 90 min before the start of physical activity.
These results suggests that any control algorithm would benefit by knowing
in advance that physical activity is impending to reduce the risk of hypogly-
cemia, because the large delay between subcutaneous insulin infusion and
its effect on plasma glucose concentration preclude the possibility of simply
stopping subcutaneous basal insulin infusion when physical activity is de-
tected. Moreover, here, if patient-specific basal insulin reduction pattern is
not available, a generic basal reduction strategy is proposed that has been
proved to be rather safe and effective.
The simulation study and its results have been published in [105].

6
Models to Assess the Effect of Exercise on
Glucose Kinetics
6.1 Introduction
It is well established that physical activity increases rates of glucose up-
take (Rd) and numerous factors determine this effect during and after exer-
cise. One of the most important regulatory responses is an increase in blood
flow [2, 92] to the contracting skeletal muscles. Moreover, it was found that
exercise increases glucose uptake in skeletal muscle through the translocation
of GLUT-4 isoform from an intracellular compartment to the surface of the
cell [48, 49, 114, 128] and increasing its transcription [39, 95], and this effect
has been demonstrated to be independent of insulin [88, 91, 97, 123]. Then,
in addition to the acute effects of exercise to increase muscle glucose uptake,
the postexercise period has been characterized by muscle being more sens-
itive to the action of insulin [51, 52], even if the mechanisms are still under
investigation.
Thus, the effect of physical activity on glucose kinetics, although qualitat-
ively well established from a physiological point of view, has been difficult to
quantify. As shown in the literature, the parameters of the minimal model
of glucose kinetics can change significantly during and after physical activity
[10, 13, 38]. For instance, in [38] a simple mathematical approach is presen-
ted, roughly illustrating the effect of physical activity in increasing glucose
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uptake and improving insulin sensitivity. In [10] this model was used in
T1DM subjects during an euglyemic-hyperinsulinemic clamp and expanded
in order to link these effects to heart rate signal. This model was further
extended in [34] to take into account for physical activity duration and in-
tensity. However, as reported in [10], some important observed dynamics
have not been addressed due to the lack of experimental data. Thus, to the
best of our knowledge, a model quantitatively describing the effect of physical
activity on postprandial glucose kinetics has never been developed and this is
an important practical issue since many people, with and without diabetes,
exercise a few hours after a meal.
In this Chapter the development of a model to assess the effect of phys-
ical activity on glucose kinetics is presented. To do that, a good model of
glucose kinetics in the specific experimental conditions described in Chapter
3 is presented. Then, using the knowledge on exercise physiology presented
in Chapter 2, a battery of models of system, incorporating the effect of phys-
ical activity, will be tested against data. Finally, the selection of the best
models on the basis of standard criteria [24] will be discussed.
6.2 Models of glucose kinetics
In order to develop a model of the effect of physical activity on glucose
kinetics, first a model describing the glucose-insulin system at rest is required.
As a remark, thanks to the availability of virtually model-independent estim-
ates of Ra meal and EGP, we can focus specifically on modeling the effect of
physical activity on glucose utilization without describing its action, if any,
on Ra meal and EGP.
The first model considered was a single-compartment labeled glucose
minimal model presented in [31]. This model exploits Ra meal as known input
and it is identified from Gmeal, i.e. the exogenous glucose deriving from the
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meal, and insulin data. For our purpose, the same model can be identified
on total glucose data by using Ra meal and EGP as known inputs, i.e. the
total rate of glucose appearance.
However, as previously discussed in Chapter 4, the rapid variations on gluc-
ose kinetics introduced by physical activity make this model inadequate to
describe glucose kinetics also during MTT/OGTT. As already reported for
the more rapid IVGTT perturbation, in this particular experimental condi-
tions, a two-compartment model better describes glucose kinetics [19, 20].
This last model has been used to accurately assess glucose metabolism in a
single individual during labeled-IVGTT [120].
The model (Figure 6.1) is reported below in its uniquely identifiable para-
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Figure 6.1: The two-compartment minimal model in its uniquely identifiable
parameterization. Q1 and Q2, glucose masses in the first (accessible pool) and
second (slowly equilibrating) compartments, respectively; I ′, concentration of in-
sulin remote from plasma; G, plasma glucose concentration; Ra meal and EGP rate
of meal glucose appearance and endogenous glucose production, respectively; V1,
volume of the accessible pool; Rd,0, constant component of glucose disposal that
accounts for inhibition of glucose clearance by glucose itself; kp, proportionality
constant; k21, k12 and k02, glucose kinetic parameters; p2 and sk, insulin action
parameters. Adapted from [120].
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meterization
Q˙1(t) = −
[
kp +
Rd,0
Q1(t)
+ k21
]
Q1(t) + k12Q2(t) + EGP (t) +Ra meal(t)
Q1(0) = Gb · V1
Q˙2(t) = k21Q1(t)−
[
k02 +X(t) + k12
]
Q2(t)
Q2(0) =
k21
k02+k12
Gb · V1
X˙(t) = −p2{X(t) + sk[I(t)− Ib]}
X(0) = 0
G(t) = Q1(t)
V1
(6.1)
where Q1(t) and Q2(t) denote glucose masses in the first (plasma plus insulin-
independent tissues, rapid equilibrating with plasma) and the second com-
partment (insulin-dependent or slowly equilibrating tissues) compartments,
respectively (mg/kg); Gb is the basal glucose concentration (mg/dL); X(t) =
sk ·I ′(t) is insulin action (min−1), where I ′(t) is the concentration of insulin re-
mote from plasma (µU/mL); I(t) and Ib are plasma insulin and basal insulin,
respectively (µU/mL); G(t) is plasma glucose concentration (mg/dL); Ra meal
and EGP are the rate of meal glucose appearance and endogenous glucose
production, respectively (mg/kg/min); V1 is the volume of the accessible
compartment (dL/kg); Rd,0 is the constant component of glucose disposal
(mg/kg/min) [20, 119] whereas kp (min−1) is the proportionality constant
between glucose disposal from the accessible compartment and glucose mass
in the same compartment; k21 (min−1), k12 (min−1) and k02 (min−1) are para-
meters describing glucose kinetics; and p2 (min−1) and sk (mL/µU/min) are
parameters describing insulin action.
Glucose disposal from the accessible pool is the sum of two components,
one constant (Rd,0) and the other proportional to glucose mass Q1 (kp),
thus accounting for inhibition of glucose clearance by glucose itself. Gluc-
ose disposal from the slowly equilibrating pool is the sum of two compon-
ents both proportional to glucose mass in the second compartment, Q2, one
insulin-independent (k02) and one insulin-dependent, this last assumed to be
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controlled by insulin in a remote compartment (X). Achieving the a priori
unique identifiability of the model requires two assumptions [20]: first, in nor-
mal subjects, in the basal stead state, insulin-independent glucose disposal is
three times insulin-dependent glucose disposal [23] leading to an additional
relation among the model parameters:
kp +
Rd,0
GbV1
= 3 · k21k12
k02k12
(6.2)
The second assumption in [120] is that Rd,0 is fixed to 1 mg/kg/min [7]. The
uniquely identifiable parameterization, as shown in [20], is thus V1, k21, k12,
k02, p2 and sk.
However, these model assumptions do not guarantee positive values for para-
meters kp in all circumstances, in fact this parameter is positive only if the
component Rd,0, which is fixed equal in all subjects (see above), is lower than
the steady-state value of glucose disposal from the accessible compartment.
Thus, to ensure positive values of kp, in [115] a new description of the con-
straint on Rd,0 is formulated which puts it in relation with the total glucose
disposal in steady state (Rssd ). In particular, it is assumed that Rd,0 account
for a fixed fraction of Rssd :
Rd,0 = αR
ss
d (6.3)
where α is constant among individuals. Values of Rd,0 and Rssd measured
in a group of nondiabetic subjects [3] suggested to fix α = 0.465. The new
assumption in Eq. 6.3, while still ensuring a priori identifiability of the model
structure, is also able to guarantee positive values of kp obtaining
kp =
k21k12
k02k12
(3− 4α) (6.4)
Finally, the model allows the estimation of:
• Glucose effectiveness (GE*, dL/kg/min) which quantifies the ability of
glucose to promote its own disposal at steady state
GE∗ =
∂Rd(t)
∂G(t)
∣∣∣∣
ss
=
(
kp +
k21k12
k02k12
)
V1 (6.5)
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where the symbol * indicates that this is glucose effectiveness on
glucose disposal only.
• Plasma clearance rate (PCR, dL/kg/min) which measures glucose dis-
posal at basal steady state, per unit glucose concentration
PCR =
Rssd
Gb
=
(
kp +
Rd,0
V1Gb
+
k21k12
k02k12
)
V1 (6.6)
• Insulin sensitivity (S*I , dL/kg/min per µU/mL) which quantifies the
ability of insulin to enhance disposal glucose effectiveness
S∗I =
∂2Rd(t)
∂G(t)∂I(t)
∣∣∣∣
ss
= sk
k21k12
(k02 + k12)2
V1 (6.7)
6.3 Models of exercise effect on glucose kinetics
Here, a set of models incorporating the effect of physical activity into the
model of glucose kinetics presented in Section 6.2 are presented. Since the
physiological interpretation of the two-compartment minimal model of gluc-
ose kinetics is that the first compartment represents the plasma plus rapid
equilibrating tissues while the second one represents the slowly equilibrat-
ing tissues, such as skeletal muscles, the effect of physical activity has been
incorporated in the second compartment. It is an accepted knowledge that
physical activity increases rates of glucose uptake by numerous factors during
and after exercise, such as increasing in blood flow [2, 92] to the contracting
skeletal muscles, insulin-independent [91, 97, 123] translocation of GLUT-4
isoform [48, 49, 114, 128] and its transcription [39, 95], and insulin sensitivity
in the postexercise period [51, 52].
Thus, ten models incorporating all or part of these effects have been tested
assuming that physical activity could affect:
• k21, representing the rate constant of influx from the first to the second
compartment.
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• sk, representing the magnitude of insulin-dependent glucose disposal of
the second compartment.
• k02, representing the magnitude of insulin-independent glucose disposal
of the second compartment.
Physical activity (PA) has been represented as a square-wave signal of unit
amplitude and its effect of glucose kinetics parameters has been assumed
to act instantaneously or delayed by a parameter d, which has also been
estimated from the data:
Model 1 : it assumes a proportional instantaneous action on k21
kPA21 = k21 · [1 + α · PA(t)] (6.8)
where α is a parameter modulating the effect of physical activity (Fig-
ure 6.2).
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Figure 6.2: Model 1 graphic representation.
Model 2 : it assumes a proportional instantaneous action on sk
sPAk = sk · [1 + β · PA(t)] (6.9)
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where β is a parameter modulating the effect of physical activity (Fig-
ure 6.3).
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Figure 6.3: Model 2 graphic representation.
Model 3 : it assumes a proportional instantaneous action onk02
kPA02 = k02 · [1 + γ · PA(t)] (6.10)
where γ is a parameter modulating the effect of physical activity (Figure
6.4).
Model 4 : it is the combination of model 1 and model 2 assuming both a
proportional instantaneous action on k21 and sk
kPA21 = k21 · [1 + α · PA(t)]
sPAk = sk · [1 + β · PA(t)]
(6.11)
where α and β are parameters modulating the effect of physical activity
(Figure 6.5).
Model 5 : it is the combination of model 1 and model 3 assuming both a
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Figure 6.4: Model 3 graphic representation.
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Figure 6.5: Model 4 graphic representation.
proportional instantaneous action on k21 and k02
kPA21 = k21 · [1 + α · PA(t)]
kPA02 = k02 · [1 + γ · PA(t)]
(6.12)
where α and γ are parameters modulating the effect of physical activity
(Figure 6.6).
98 Models to Assess the Effect of Exercise on Glucose Kinetics
Plasma 
Glucose 
Q1 
Tissue 
Glucose 
Q2 
Remote 
Insulin 
I’ 
k21 
k12 
k01(t) = kp + Rd,0/Q1(t) k02 
G1=Q1/V1 
p2 p2 
sk 
Ra meal(t) + EGP(t) 
[I(t) – Ib] 
PA(t) 
 
 
Figure 6.6: Model 5 graphic representation.
In some of the following models a delayed version of physical activity PA'(t)
˙PA′(t) = −d · PA′(t) + d · PA(t) (6.13)
may be used, instead of PA.
Model 6 : it assumes a proportional delayed action on k21
kPA
′
21 = k21 · [1 + α · PA′(t)] (6.14)
where α is a parameter modulating the effect of physical activity (Fig-
ure 6.7).
Model 7 : it assumes a proportional delayed action on sk
sPA
′
k = sk · [1 + β · PA′(t)] (6.15)
where β is a parameter modulating the effect of physical activity (Fig-
ure 6.8).
6.3 Models of exercise effect on glucose kinetics 99
Plasma 
Glucose 
Q1 
Tissue 
Glucose 
Q2 
Remote 
Insulin 
I’ 
k21 
k12 
k01(t) = kp + Rd,0/Q1(t) k02 
G1=Q1/V1 
p2 p2 
sk 
Ra meal(t) + EGP(t) 
[I(t) – Ib] 
Delayed 
Exercise 
PA’ 
d d 
PA(t) 
 
Figure 6.7: Model 6 graphic representation.
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Figure 6.8: Model 7 graphic representation.
Model 8 : it assumes a proportional delayed action on k02
kPA
′
02 = k02 · [1 + γ · PA′(t)] (6.16)
where γ is a parameter modulating the effect of physical activity (Figure
6.9).
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Figure 6.9: Model 8 graphic representation.
Model 9 : it is the combination of model 1 and model 7 assuming a propor-
tional instantaneous action on k21 and a proportional delayed action
on sk
kPA21 = k21 · [1 + α · PA(t)]
sPA
′
k = sk · [1 + β · PA′(t)]
(6.17)
where α and β are parameters modulating the effect of physical activity
(Figure 6.10).
Model 10 : it is the combination of model 1 and model 8 assuming a pro-
portional instantaneous action on k21 and a proportional delayed action
on k02
kPA21 = k21 · [1 + α · PA(t)]
kPA
′
02 = k02 · [1 + γ · PA′(t)]
(6.18)
where α and γ are parameters modulating the effect of physical activity
(Figure 6.11).
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Figure 6.10: Model 9 graphic representation.
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Figure 6.11: Model 10 graphic representation.
6.4 Model identification
As reported in [115, 120] the parameters of glucose kinetics are a priori
uniquely identifiable. Moreover, in each presented model, the inclusion of
the parameters describing the effect of physical activity did not modify the
identifiability properties of the whole model, thus allowing to estimate all
parameters at the same time. However, due to the high numbers of paramet-
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ers to be estimated in relation to available data, a Maximum A Posteriori
(MAP) Bayesian estimator approach was adopted to improve a posteriori
identifiability of the model. Data are weighted with the inverse of the vari-
ance of glucose measurement errors, which was assumed to be independent,
Gaussian with zero mean and known coefficient of variation equal to 2%.
Plasma insulin and physical activity signals were the models forcing func-
tions assumed to be known without error. In particular, physical activity was
assumed to be a square-wave signal of unit amplitude between t = 120− 195
min and zero elsewhere. The method provided both optimal values for model
parameters and a measure of their precision.
6.5 Model selection
Each model described in Section 6.3 has been identified against data.
Data are presented as mean ± SE, if not differently indicated. All results
were averaged on a total of 11 subjects, since an error on the measurement
of meal enrichment was reported in one subject. Values obtained at t = 0
min were considered as basal. In the following Figures, shaded box between
t = 120 and t = 195 min represents the exercise period at 50% V˙O2max.
Models were compared on the basis of standard criteria [24]:
• Residual independence (Runs Test).
• Ability to describe the data (Weighted Residual Sum of Squares, WRSS).
• Precision of parameter estimates (expressed as CV).
• Model parsimony (Bayesian Information Criterion, BIC).
Table 6.1 shows the quantitative results used for model selection. All the
tested models fitted the data sufficiently well, as confirmed by the Runs
Test, which supported randomness of residuals in most of individuals for
each model. Among models, one can observe that parameter α was always
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estimated with a good precision and its identification guarantees full ran-
domness of residuals and provided, on average, lower weighted residuals and
parsimony indices (model 1, model 4, model 5, model 6, model 9 and model
10). However, comparing model 1 and model 6, the presence of the delay
parameter on the effect of physical activity d in model 6 worsens model pre-
diction against data (higher average WRSS) and reduces the capability of
the model to the estimate an exercise-induced effect in 18% of subjects with
respect to model 1. For this reason, all the models including an effect on k21
assumed an instantaneous effect of physical activity on k21 (α).
In contrast, model 2 and model 7 (assuming the effect of physical activity on
sk) provided the worst model predictions against data, with respect to the
other candidates, with low precision of parameters estimates. Furthermore,
model 3 and model 8 (assuming the effect of physical activity on k02) provided
better model predictions if compared to model 2 and model 7, respectively,
but worse than model 1 and model 6, respectively. For this reason, these
models have been discarded. Finally, the improvement in model prediction
introduced by parameter β with respect to simpler or similar models sugges-
ted that, in this particular database, this effect is not as relevant as expected.
Increasing the complexity of the model, model 4, model 5, model 9 and model
10 allowed to better describe data, i.e. supporting the randomness of the
residuals in all subjects, reducing WRSS and the parsimony index, although
the number of parameters is greater than their simpler versions. However,
the risk of increasing the number of parameters is that sometimes not all
the parameters are a posteriori identifiable. In fact, model 4 collapsed in
model 1 in 4 subjects, since parameter β was estimated equal to zero, and in
model 2 in 1 subject, since parameter α was estimated equal to zero; model
5 collapsed in model 1 in 6 subjects, since parameter γ was estimated equal
to zero; model 9 collapsed in model 1 in 3 subjects, since parameter d and/or
sk were estimated equal to zero.
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Figure 6.12: Average glucose data vs. models prediction (left) and weighted
residuals (right). Model 1 (top), model 5 (middle) and model 10 (bottom). Vertical
bars represent SE for glucose data and SD for weighted residuals.
In general, the parsimony criterion indicates model 10 as the most parsi-
monious (lowest BIC) despite being the most complicated. This is due to the
ability of the model to well describe the data (lowest WRSS) still providing
a good precision of parameter estimates. However, the main drawback of
this model is the large variability of d estimates (range: 1 ÷ 0.004 min−1),
resulting in an average value of 0.11± 0.30 min−1, and in the fact that d in
some cases is difficult to estimate. This is likely due to the sampling schedule
(every 10 min during exercise session) and the duration of the experiment
(360 min). In addition, despite being less accurate than model 10, the two
models which satisfy most of the selection criteria are model 1 and model 5.
These 3 models share parameter α, which always guaranteed full random-
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ness of residuals and was accurately and precisely estimated (0.49 ± 0.32,
0.56± 0.22 and 0.56± 0.22 for model 1, model 5 and model 10, respectively;
with CV equal to 13 ± 12%, 26 ± 39% and 12 ± 4% for model 1, model 5
and model 10, respectively); while model 5 and model 10 share parameter γ
(12.8± 8.0 and 13.2± 7.9, respectively).
In Figure 6.12, average glucose data vs. models prediction and weighted
residuals for model 1, model 5 and model 10 are reported. As can be ob-
served, all models fitted the data well as confirmed by inspection of visual
predictive check (VPC) of model prediction vs. plasma glucose data and
the corresponding weighted residuals, which present zero mean and are suf-
ficiently random.
All the models proposed here have been developed based on the available
knowledge on exercise physiology, and thus allowing a direct physiological in-
terpretation of the estimated parameters. A set of models, model 1, model 5
and model 10, have been demonstrated to significantly improve prediction of
glucose data during physical activity.
The best models proposed share the assumption that exercise affects para-
meter k21 and this is seemed to be fundamental to describe glucose kinet-
ics during physical activity. From a physiological point of view, this effect
may be interpreted as the increase in muscle blood flow, in agreement with
[2, 92], and, at least in part, glucose uptake by the muscles. In fact, as can
be observed in Eqs. 6.5 and 6.7, an increase in k21 augments both gluc-
ose effectiveness and insulin sensitivity. In addition, model 5 and model 10
also assume that physical activity stimulates the insulin-independent gluc-
ose disposal which takes place in the second compartment, k02. From a
physiological point of view, this effect may be interpreted as an increase in
insulin-independent glucose uptake, e.g. increased translocation and tran-
scription of GLUT-4 isoform and/or glucose oxidation, in agreement with
[39, 48, 49, 88, 91, 95, 97, 114, 123, 128]. In contrast, in this particular
database, we were not able to specifically modeling the well-known postex-
ercise increase in insulin action [51, 52]. This is likely due to the fact that,
in healthy subjects, insulin is markedly suppress during physical activity
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(Figure 3.1, top right). It is worth noting that, since insulin is returned
to its basal value in this phase, the effect of exercise of insulin-dependent
utilization may be included in the estimated increase of k02, thus including
both insulin-independent and -dependent effect. Furthermore, as reported
in [45, 60], another possible explanation may be due the time-domain of this
database in relation to time at which the increase in insulin sensitivity may
occur (3-4 hours later).
However, the above reported results are not in contrast with those reported in
Chapter 5, i.e. that exercise increase the overall insulin sensitivity by almost
75%. In fact, the overall insulin sensitivity can be calculated from model
parameters using Eq. 6.7, thus an increase in k21 implies an exercise-induced
increase in overall SI .
In conclusion, the models presented in this Chapter well describe the
data and allow the quantification of physiologically interpretable paramet-
ers. However, future studies with different protocols, e.g. injecting an in-
sulin bolus after the exercise session or lasting longer, are needed to valid-
ate the proposed models and better understand the contribution of insulin-
independent and -dependent effect of physical activity on glucose disposal.

7
Conclusions
In healthy subjects, glucose regulation relies on a complex control system
that keeps blood glucose level within a narrow range around its basal value.
An important component of everyday life challenging this complex mechan-
ism, although offering a net benefit for most individuals with and without
diabetes, is regular physical activity.
Regular physical activity is known to have several potential benefits that ap-
ply to both diabetic and nondiabetic individuals such as enhancing insulin
sensitivity, improving glycemic control and reducing the risk of cardiovascu-
lar mortality. Psychological benefits of exercise, such as an increased sense
of well-being, improved self-esteem and enhanced quality of life may also be
important for those with either type 1 and type 2 diabetes [61]. Although
persons with diabetes may derive many benefits from regular physical activ-
ity, there are also a number of hazards that make exercise difficult to manage
if not properly addressed.
Numerous studies have demonstrated increased rate of glucose disappearance
(Rd) and endogenous glucose production (EGP) during physical activity in
individuals with and without diabetes [46, 64] in the postabsorptive state,
while very few have examined the effects of exercise in the postprandial state
in individuals with and without type 2 diabetes [17, 18, 58, 65, 74, 75] and
none in individuals with type 1 diabetes, although many people, with and
without diabetes, exercise a few hours after a meal. Furthermore, very few
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studies [27] have used methods that minimize fluctuations in tracer-to-tracee
specific activity to enable accurate continuous (every 10 min) measurement
of glucose turnover and during the transition from rest to exercise in nondia-
betic subjects.
A method for the quantification of the effect and effect size of exercise on
insulin sensitivity and a physiological model quantitatively describing the ef-
fect of exercise on glucose turnover in the postprandial state have never been
developed so far. This represents a significant knowledge gap, especially in
type 1 diabetes, because this information could be incorporated into cur-
rently available artificial pancreas control algorithms, thus extending their
applicability to treat people with type 1 diabetes. However, such tools will
need to be developed and tested in healthy subjects before validating in those
with diabetes.
The aim of this contribution is to develop a methodology to accurately
quantifying the effect of moderate-intensity physical activity on postprandial
glucose turnover in healthy subjects. A novel method for the estimation of
postprandial glucose turnover during physical activity with the state-of-the-
art techniques has been established. Then, exploiting the obtained results,
first a method for the quantification of the effect and effect size of exercise
on postprandial insulin sensitivity has been developed, then a whole-body
mathematical model describing the effect of physical activity on glucose-
insulin system was developed and tested on the available data. To address
these tasks, data of 12 healthy individuals who underwent a triple-tracer
mixed-meal and a moderate-intensity exercise session 2 hours after meal in-
gestion for 75 minutes have been used [104].
The tracer-to-tracee clamp technique is a well-established method [4]
which allows to accurately estimate postprandial glucose fluxes continuously
after a meal in a model-independent way by infusing tracers in order to min-
imize fluctuations in tracer-to-tracee ratio (TTR). However, since it is almost
impossible to realize a perfect clamp of the plasma tracer-to-tracee ratio,
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the use of models, to compensate the non-steady-state errors, is needed. Use
of models requires the estimation of derivatives both for tracer-to-tracee ra-
tio and glucose signals. Due to ill-conditioning, this issue was first addressed
thanks to a stochastic deconvolution technique [36], where the expectations
of the smoothness of the unknown input signal is a priori described as mul-
tiple integrations of a stationary white noise process. However, because of
physical activity, signals represented marked nonstationarity leading us to
resort to an improved stochastic deconvolution method [90]. The proposed
method allows to relax the usual stationarity assumption and, since prior
information of the input signal was unknown, an hypothesis to account for
the different behaviours of the input signal has been assumed. Results show
that, at variance with the standard technique, the proposed method provides
a good regularization of TTR and glucose signals, and thus their derivat-
ives, able to follow the rapid changes in these signals induced by exercise.
Moreover, in addition to the method proposed in [90] for the quantification
of the parameters describing the different behaviours of the input signal, a
new criterion is proposed that has been proved to allow a more smoothed
reconstruction of TTR and glucose signals. The proposed method allows an
accurate reconstruction of postprandial glucose fluxes after the meal, dur-
ing and after the exercise session. Fluxes analysis show a rapid eightfold
increase of EGP with a pleateau in the rates of both Ra meal and Rd during
exercise, while glucose concentrations rapidly falls below basal fasting levels
in all subjects, accompanied by a rapid fall in insulin concentrations and a
greater than twofold rise in glucagon concentrations.
A method for the quantification of the effect and effect size of exercise
on net insulin sensitivity (SI), i.e. the ability of insulin to stimulate glucose
disposal (Rd) and suppress endogenous glucose production (EGP), and eval-
uate the relative contribution of liver and disposal insulin sensitivity is also
presented. The method is based on the estimation of SI using data of first
2 hours after the meal, i.e. in absence of physical activity (rest), and then
using the data of the whole experiment, i.e. in presence of physical activity
(overall).
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SI is thus derived from reconstructed postprandial glucose fluxes. Results
show that net insulin sensitivity increases by almost 76±12% during moderate-
intensity exercise and that this increase is due to an enhancement in gluc-
ose disposal rather than a further suppression of EGP. This effect, from a
physiological point of view, may be due to the relatively minor inhibitory ef-
fect of insulin on EGP compared to the stimulatory effect of glucagon, while
a significant effect seems to be exerted by insulin on glucose disposal due to
sustained rate of Rd during exercise, even though insulin and glucose rapidly
fell.
In order to validate the obtained results, the same rationale was applied to
the well-established integral formula proposed in [21] to estimate SI from
plasma glucose and insulin concentrations. Results show a similar increase
in net insulin sensitivity (74±8%). The comparison between the two meth-
ods shows that they provide similar values of net insulin sensitivity and the
correlation between the two was very high (r=0.989, p0.005).
However it is important to remark that, with the proposed method, it is
possible only to measure an insulin-dependent effect of exercise on glucose
disposal while, unfortunately, it is not possible to tease out the relative contri-
bution of well-established insulin-independent mechanisms induced by phys-
ical activity [48, 49, 114, 128].
Incidentally, these results have been incorporated into the UVA/Padova
T1DM simulator in order to suggest the best strategy that could be ad-
opted during artificial pancreas clinical trials that involves a session of mod-
erate physical activity. In this work it is showed that, in order to prevent
hypoglycemia during and after exercise, any control algorithm would be-
nefit by knowing in advance of upcoming physical activity, due to the large
delay between subcutaneous insulin infusion and its effect on plasma glucose.
Moreover, in the case that patient-specific basal insulin reduction pattern is
not available, an optimal basal reduction strategy is suggested which has
been proved to be rather safe and effective in simulation studies [105].
As previously discussed, the method for the quantification of the effect
size of exercise on insulin sensitivity is not able to tease out the insulin-
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independent effect of exercise on glucose uptake. Therefore, to discriminate
the effect of exercise on insulin-dependent and -independent glucose turnover,
the development of a model of system is needed.
Starting from a two-compartment model to describe glucose kinetics, a set
of models of increasing complexity, incorporating the modulating effect of
physical activity on glucose kinetics parameters were developed. The se-
lection of the best models was tackled using standard criteria (e.g. abil-
ity to describe the data, precision of parameter estimates, model parsi-
mony, residual independence). The best selected models share the assump-
tion that exercise increase the model parameter representing the rate con-
stant influx from the first (plasma plus insulin-independent tissues, rapid-
equilibrating with plasma) to the second compartment (insulin-dependent or
slowly-equilibrating tissues, such as skeletal muscles). This effect may be
interpreted as an increase in muscle blood flow, in agreement with [2, 92],
and, at least in part, glucose uptake by the muscles. In addition, more com-
plicated models also assume that exercise stimulates the insulin-independent
glucose disposal parameter in the second compartment, which may be in-
terpreted as an increase in insulin-independent glucose uptake, in agreement
with [39, 48, 49, 88, 91, 95, 97, 114, 123, 128]. In contrast, in this par-
ticular database, we were not able to specifically modeling the well-known
postexercise increase in insulin action, mainly due to the fact that, in healthy
subjects, insulin is markedly suppress during physical activity.
However, it is important to remark that these results are not in contrast with
those obtained with the integral method, since the calculation of an index of
insulin sensitivity from model parameters, incorporating the above estimated
effects of physical activity, implies an exercise-induced increase in the overall
insulin sensitivity.
In conclusion, in this study, a methodology to accurately quantifying
the effect of moderate-intensity physical activity on postprandial glucose
turnover in healthy subjects has been developed. A novel method, using the
triple-tracer technique, for the estimation of postprandial glucose turnover
which accounts for the nonstationarity introduced by physical activity has
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been established. Then, a method for the quantification of the effect of phys-
ical activity on whole-body insulin sensitivity has been developed. Finally, a
whole-body mathematical model describing the effect of physical activity on
glucose-insulin system was developed.
Future studies with different protocols, e.g. injecting an insulin bolus after
the exercise session and lasting longer, and/or with different subjects, e.g.
T1DM subjects, are needed to validate the proposed techniques and to ex-
pand the knowledge on the effect of physical activity on glucose-insulin reg-
ulation.
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